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INTRODUCTION 
 
On June 25, 2000, President Bill Clinton and Prime Minister Tony Blair jointly announced 
the completion of the draft sequence of the human genome. The National Human Genome 
Research Institute reported that the completion of the Human Genome Project cost 
approximately $2,700,000,000 (in 1991 dollars, approximately $4,330,000,000 in 2010 dollars). As 
of this writing, several commercial personal genomics companies offer complete genome 
sequencing to anyone willing to pay approximately $40,000 – nearly six orders of magnitude 
cheaper than what a genome would have cost about a decade ago. The potential for incalculable 
profits are a driving force behind the academic and commercial development of second and third 
generation sequencing instrumentation, which will no doubt enable the coveted $1,000 genome 
within the next 5 years or less. This relentless progression of technology in combination with the 
collection of extremely large cohorts has revolutionized the field of disease gene research. 
Although whole genome sequencing in thousands of samples is still a few years away, the last 
few years of disease gene research have been marked by the rise of the genome-wide association 
study (GWAS) as a preferred method for studying the genetic architecture of common diseases. 
In this dissertation I focus on study design principles, quality control procedures, and new 
analytical procedures that can be used in genome-wide association studies. I focus on the role 
that epistasis, or gene-gene interaction, plays in the genetic architecture of common disease, and 
how we might investigate epistasis in GWAS. I conclude this dissertation with a GWAS 
investigating the genetic and environmental factors that impact HDL-cholesterol levels in 
humans – a known heritable risk factor for cardiovascular disease and a potential therapeutic 
target of high public health interest. 
Chapter I begins this dissertation with a review of study designs and analytical methods 
for genetic association studies partially adapted from Turner, S. D., Crawford, D. C., & Ritchie, 
M. D. (2009), “Methods for optimizing statistical analyses in pharmacogenomics research,” Expert 
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Review of Clinical Pharmacology, 2(5), 559-570. This chapter explores principles of study design and 
statistical analysis for genetic association studies, including discussions of the importance of 
phenotyping and choosing an appropriate study population. Traditional statistical techniques for 
analyzing quantitative traits are reviewed, and the chapter concludes with an examination of new 
and emerging methodologies for analysis beyond simple single-locus effects, including an 
overview of the knowledge-driven evolutionary computing concept that forms the subject of the 
following chapter. 
Chapter II discusses the motivation, development, and in silico assessment of ATHENA – 
the Analysis Tool for Heritable and Environmental Network Associations. ATHENA is an 
analytical platform that allows domain knowledge from publicly available biological repositories 
to be incorporated into a memetic algorithm for training neural networks which utilizes both 
backpropagation and grammatical evolution. This chapter is adapted in part from my series of 
three peer-reviewed articles on the method: [1] Turner, S. D., Dudek, S. M., & Ritchie, M. D, 
(2010), “Grammatical Evolution of Neural Networks for Discovering Epistasis among 
Quantitative Trait Loci,” Lecture Notes in Computer Science, 6023, 86-97; [2] Turner, S. D., Dudek, S. 
M., & Ritchie, M. D, (2010), “Incorporating Domain Knowledge into Evolutionary Computing for 
Discovering Gene-Gene Interaction,” Lecture Notes in Computer Science, 6238(I), 394-403; and [3] 
Turner, S. D., Dudek, S. M., & Ritchie, M. D, (2010), “ATHENA: A Knowledge-Based Hybrid 
Backpropagation-Grammatical Evolution Neural Network Algorithm for Discovering Epistasis 
among Quantitative Trait Loci,” BioData Mining, 3:5. 
In Chapter III, I use genome-wide transcriptome data and genome-wide SNP data from 
HapMap lymphoblastoid cell lines to examine a heretofore unexplored mechanism for epistasis 
to affect human traits. It is common knowledge that many human traits are driven by alterations 
in gene expression. It is also well accepted that common genetic variation affects the expression 
of nearby genes (Veyrieras et al., 2008). Furthermore, a common theme argued in this dissertation 
and elsewhere is that epistasis is ubiquitous and affects human traits (Manolio, 2010; Moore, 
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2003). Combining these three ideas, is it possible that genetic variation can interact epistatically to 
exert a cis-regulatory effect on the expression of nearby genes? If so, what is the genomic and 
statistical structure of these epistatically interacting multilocus models? Are genes which are 
affected by cis-epistasis associated with complex human disease or morphological phenotypes? If 
so, how might we use this knowledge to guide the reanalysis of existing datasets, and how might 
we incorporate this information into the ATHENA algorithm discussed in Chapter II? These 
questions are explored in Chapter III, which is partially adapted from a peer-reviewed 
manuscript, accepted for publication in early 2011 in the proceedings of the personal genomics 
session of the Pacific Symposium in Biocomputing: Turner, S.D., Bush, W.S., (2011), “Multivariate 
Analysis of Regulatory SNPs: Empowering Personal Genomics by Considering cis-Epistasis and 
Heterogeneity.” 
After discussing methodology in Chapters I-II and an alternative mechanism for epistasis 
in Chapter III, we move to quality control and analysis of natural, biological data in Chapters IV-
V. Thorough quality control (QC) is of utmost importance when analyzing high-throughput 
GWAS datasets. Systematic biases that result in the deviation of test statistics from the truth are 
amplified with the extremely large sample sizes characteristic of contemporary GWA studies. For 
this reason I dedicate the entirety of Chapter IV to discussing the QC procedures that were used 
prior to the analyses that will be presented in Chapter V. I led the eMERGE genomics working 
group in developing this set of procedures and reporting them in a manuscript now accepted and 
in press at Current Protocols in Human Genetics: Turner S.D., Armstrong L., Bradford Y., Carlson 
C., Crawford D.C., Crenshaw A.T., de Andrede M., Doheny K., Haines J.L., Hayes G., Jarvik G., 
Jiang L., Ling H., Kullo I., Li R., Manolio T.A., Matsumoto M., McCarty C.A., McDavid A., Mirel 
D., Paschall J., Pugh E., Rasmussen L.V., Wilke R.A., Zuvich R.L., Ritchie M.D., (2011),  “Quality 
Control procedures for Genome-Wide Association Studies.” The eMERGE consortium has agreed 
on this set of QC procedures as a set of best practices guidelines for QC of GWAS data. In 
addition to serving as documentation of the QC procedures used prior to the analyses presented 
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in the next chapter, this chapter may also be used as a set of guidelines for future investigators 
executing quality control on GWAS data. 
In Chapter V, I perform a genome-wide association study investigating genetic and 
environmental factors that contribute to high density lipoprotein cholesterol (HDL-C) level.  
Although HDL-C levels are highly heritable, the genetic determinants identified through GWAS 
thus far only explain a small proportion of the variance in this trait. Reasons for this discrepancy 
may include rare variants, structural variants, gene-environment interaction, and gene-gene 
interaction. The world’s growing clinical practice-based biobanks now allow investigators to 
address these challenges, by conducting GWAS in the context of comprehensive electronic 
medical records. Here I apply a novel EMR-based phenotyping approach, within the context of 
routine care, to replicate several known associations between HDL-C and previously 
characterized genetic variants. Through the application of additional analytical strategies 
incorporating biological knowledge similar to those presented in Chapter II, I further identified 
11 significant gene-gene interaction models in a discovery cohort, 6 of which show evidence of 
replication in a second biobank cohort.  The results presented here illustrate the power of linking 
electronic medical records to GWAS data from biobanked samples in genetic association studies 
and in the elucidation of gene-gene interactions for complex human traits. This work is adapted 
in part from Turner S.D., Berg R.L., Linneman J.G., Peissig P.L., Crawford, D.C., Denny J.C., 
Roden D.M., McCarty C.A., Ritchie M.D., Wilke R.A., Knowledge-driven multi-locus analysis 
reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked 
biobanks, PLoS ONE, in review. 
In Chapter VI, I conclude this dissertation summarizing the work presented in Chapters 
I-V. I will also discuss the future directions of the work presented here in light of the challenges 
that must be faced as technology inexorably marches forward. 
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CHAPTER I 
 
REVIEW OF DESIGN PRINCIPLES AND METHODS FOR STATISTICAL 
ANALYSIS OF COMPLEX HUMAN QUANTITATIVE TRAITS1 
 
Introduction 
Much evidence exists suggesting that individual variation in complex human traits can 
be attributed to genetic variation (Garrod, 1902; Altshuler, Daly, & Lander, 2008; Goldstein, 2009; 
Hirschhorn, 2009). The last several decades have ushered in technological advances that have 
allowed investigators to progress from coarse genomic coverage with linkage maps and 
candidate gene association studies, to very high resolution association studies using single 
nucleotide polymorphisms (SNPs) (Risch & Merikangas, 1996). The initial completion and 
ongoing development of the International HapMap Project (International hapmap consortium, 
2003; International hapmap consortium, 2007) catalogs common human genetic variation at 
millions of polymorphic sites in several diverse human populations, facilitating more powerful 
and strategic association study designs. Several contemporary genotyping technologies enable 
rapid, highly accurate genotyping of up to millions of common SNPs at low cost per genotype 
(Spencer, Su, Donnelly, & Marchini, 2009). The genome-wide association study (GWAS) is a 
widely used technique in human genetics research to investigate DNA variations associated with 
common human diseases (Manolio, 2010; Hardy & Singleton, 2009a). In addition to SNPs, the 
latest generation of GeneChips (Affymetrix) and BeadChips (Illumina) contain thousands of 
probes targeting known copy number variations (CNV) based on the first generation CNV maps 
available for the human genome (Itsara et al., 2009; McCarroll et al., 2008; Jakobsson et al., 2008; 
Redon et al., 2006).  Finally, much research is being pursued in both the academic and private 
sector to develop methods for inexpensive whole-genome next-generation sequencing (Mardis, 
                                                     
1
 Adapted in part from: Turner, S. D., Crawford, D. C., & Ritchie, M. D. (2009). “Methods for optimizing 
statistical analyses in pharmacogenomics research,” Expert Review of Clinical Pharmacology, 2(5), 559-
570. 
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2008; Schuster, 2008; Von Bubnoff, 2008) allowing for complete examination of all human genetic 
sequence variation, which will capture rare variation that is currently missed in GWAS. 
In addition to benefitting from the technological advances in the field, genetic association 
studies can benefit from much of the recent improvements in study design and optimization of 
statistical methodology that has recently transformed disease-gene association studies.  Here, I 
review the study designs and statistical methodology that are commonly used in genetic studies 
of quantitative trait outcomes (quality control procedures for genome-wide association studies is 
the subject of extensive review in Chapter IV, and are not covered in detail in this chapter). I then 
discuss novel methodology research taking place in the human genetics community, and how 
these can be applied to optimize statistical analyses in genetic research.  A flowchart 
representation of the main topics covered in this review is shown in Figure 1.  
 
Phenotype selection and quantitative outcomes 
 
The predominant study design for genetic association studies over the last decade has 
been the case-control design.  In a disease gene association study, one would typically associate 
an allele or genotype frequency difference between affected and unaffected individuals (Haines 
& Pericak-Vance, 1998).  The case-control design in disease gene studies has many advantages, 
namely the fact that relatively rare conditions can be ascertained after their onset, significantly 
reducing the costs of ascertainment and follow-up typically incurred by large prospective studies 
(Leon Gordis, 2008).  The case-control design may be the most appropriate design in genetic 
studies examining a purely discrete outcome such as a cancer diagnosis or an extreme adverse 
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Figure 1. Design and statistical workflow of a genetic association study. This flowchart shows a general 
overview of a genetic association study with emphasis on analysis beyond single locus effects. ANOVA: 
Analysis of Variance; CPM: Combinatorial Partitioning Method; gMDR: Generalized Multifactor 
Dimensionality Reduction; SNP: Single Nucleotide Polymorphism.  
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drug reaction, where the phenotype neatly falls into one of two possible classes.  However, 
analysis of a quantitative trait that varies continuously over a range of possible values may be 
more optimal in many cases.  First, the phenotype of interest in many genetic studies naturally 
varies on a continuous scale.  This is especially true in pharmacogenetic studies. Examples 
include determining the correct stable dosage for a drug with a narrow therapeutic range (Klein 
et al., 2009; Sills, 2005; Arranz et al., 2000), predicting treatment efficacy (Nagasubramanian, 
Innocenti, & Ratain, 2003; Wessels et al., 2007; Roses et al., 2007), and predicting drug resistance 
(Siddiqui et al., 2003).  Furthermore, even many adverse drug reactions, which are typically 
thought of as discrete events, can be measured on a continuous scale, rather than discretized 
based on an often arbitrary threshold.  Examples include analyzing blood iron content rather 
than anemic status yes/no, assaying liver enzyme activity rather than hepatotoxicity yes/no, or 
recording blood glucose concentration rather than hypoglycemia status yes/no.  While artificially 
creating a discrete variable based on an arbitrary threshold in a naturally continuous trait can 
simplify analysis of the data, it can also be counterproductive as it comes with the cost of a 
dramatic decrease in statistical power (MacCallum, Zhang, Preacher, & Rucker, 2002).  That is, 
the useful variance found in continuous outcome data is discarded in dichotomous outcome data.  
Therefore, creating categorical variables in such a way should be avoided as much as possible.  
Such genetic association study designs are common in cardiovascular genetics (Aulchenko et al., 
2009; Sabatti et al., 2009; Kathiresan et al., 2009; Newton-Cheh et al., 2009; Willer et al., 2008b), 
genetic analysis of gene expression levels (eQTLs) (Cookson, Liang, Abecasis, Moffatt, & Lathrop, 
2009; Dixon et al., 2007a; Veyrieras et al., 2008; Pickrell et al., 2010), and psychiatric genetics 
(Meyer-Lindenberg & Weinberger, 2006).  Finally, standard clinical chemistry and contemporary 
proteomics techniques have made collection of continuously varying biomarker traits relatively 
easy, accurate, and inexpensive (Cristea, Gaskell, & Whetton, 2004). 
Regardless of whether the clinical outcome under investigation is a discrete or 
continuous endpoint, phenotype definition is crucial to optimizing statistical analysis for genetic 
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association studies.  This may be exceedingly difficult when a naturally continuous clinical 
outcome must be categorized into one class or another.  However, even when a quantitative 
outcome is ascertained and recorded, care must be taken to select a continuously varying clinical 
feature that can be precisely defined and reliably measured.  This is less challenging for some 
phenotypes than others. For instance, personality traits are exceedingly difficult to categorize and 
quantify, while circulating plasma lipid levels can easily be measured and recorded through 
medical record surveillance and by standard laboratory assays, respectively. Perhaps this is why 
the largest GWAS to date investigating personality traits found not a single significant result 
(Verweij et al., 2010), and why genetic factors underlying blood lipid levels have been studied 
more using GWAS than most other human phenotypes (Aulchenko et al., 2009; Chasman et al., 
2008; Heid et al., 2008; Johansen et al., 2010; Kathiresan et al., 2007; Kathiresan et al., 2008; 
Kathiresan et al., 2009; Kooner et al., 2008; Sabatti et al., 2009; Sandhu et al., 2008; Saxena et al., 
2007; Wallace et al., 2008; Willer et al., 2008b). Finally, thoughtful consideration must be given to 
choosing which clinical features will be used to represent complex disease endpoints.  In addition 
to affecting the power of statistical analyses, the choice and specificity of phenotype definition 
have implications on the interpretation and reproducibility of one's results.  Standard measures 
should be used so that others may follow up and replicate the analysis of an identical outcome in 
another dataset. 
In summary, while the case-control design has dominated genetic association studies in 
recent years, continuous outcomes may be more readily ascertained in genetic association 
studies, and the methods designed to analyze this type of outcome (discussed below) tend to be 
statistically more powerful, taking into account the full range of phenotypic variability that may 
be influenced by genetic factors.  It is important to choose an outcome that is reliably measured, 
and one that is a standard measure in the field so that others may easily follow up results in 
future studies. 
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Choosing a study population and methods for addressing stratification 
 
One of the largest sources of confounding in association studies using unrelated 
individuals stems from population stratification, which occurs when the study population 
contains multiple subgroups of individuals with distinct genetic backgrounds (usually the result 
of including multiple racial or ethnic subgroups into a single study population).  This becomes 
problematic and leads to systematic type I and type II errors (Marchini, Cardon, Phillips, & 
Donnelly, 2004) when two conditions apply: (1) The subgroups differ with respect to the 
frequency of an allele, and (2) The subgroups have different average values for the quantitative 
outcome of interest (or differ in the frequency of the occurrence of an event if the outcome under 
investigation is categorical).  There are great differences in allele frequency and linkage 
disequilibrium patterns between populations worldwide (International hapmap consortium, 
2003; International hapmap consortium, 2007). Others have furthermore shown that genetic 
variation mirrors geography within European populations alone (Novembre et al., 2008). If a 
truly irrelevant polymorphism was more common in the subgroup that, for some other genetic or 
non-genetic reason, has a higher or lower average value for the trait being studied, then the allele 
will appear associated with trait in this dataset.  The association here would be purely artifactual, 
resulting from the failure to adjust for population stratification. Also, admixture and unknown 
and/or unintentional population stratification leads to artificially increased linkage 
disequilibrium across the genome or genomic regions being studied (Zhu, Tang, & Risch, 2008).  
While this phenomenon is used as a tool in admixture mapping, it adversely affects genetic 
association studies employing a tagSNP or other LD-based approach to identifying the causal 
genetic variant regardless of whether or not the trait of interest varies between or across the 
subgroups. Thus, in addition to causing excessive type I error inflation, population stratification 
could also obscure true genetic associations (Marchini et al., 2004).   
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Selecting a population to minimize stratification   
One solution to this problem is to use family-based designs, which are robust to 
population stratification (Cardon & Bell, 2001; Cardon & Palmer, 2003).  Rather than associating 
frequency of alleles across families, family based designs typically link or associate outcomes to 
regions of genetic variation by following alleles through meioses within families, which are 
robust to confounding by population substructure. While this has been an important design for 
disease gene association studies it is used less often than population-based designs because it is 
often more difficult to ascertain the extremely large sample sizes typically required in GWAS 
analysis using a family based design. Therefore, discussions of statistical procedures used for 
family-based study designs will not be summarized here, but they are the subject of an extensive 
review available in (Laird & Lange, 2006).   
One strategy for avoiding bias introduced by population stratification is to ensure that 
study samples are drawn from a genetically homogenous population.  For example, the 
Framingham Heart Study (Govindaraju et al., 2008) original and offspring cohorts are mainly 
comprised of Americans of European descent, where the most common self-reported ancestry 
was western European.  As expected, this geographically and racially homogenous population 
does not display any evidence of population substructure (Wilk et al., 2005).  However, it is likely 
that findings in one genetically homogenous population may not replicate or explain disease 
susceptibility variance in other ethnic groups or in the broader general population (Ioannidis, 
Thomas, & Daly, 2009).  Furthermore, one of our goals as geneticists is to understand biology and 
enable personalized medicine in all humans, not just one genetically homogenous subset. 
Therefore, diverse population-based samples are desirable for genetic association studies focused 
on characterizing previous GWAS or candidate gene discoveries made in one population 
(Manolio, 2009). In addition to intentionally studying diverse populations, ascertainment of 
diverse samples may be unavoidable due to economics, ease of recruitment, and recruitment 
setting (such as an outpatient clinic in a diverse city).  If sampling from a diverse population for a 
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genetic association study, care should be taken to record ancestry and ethnic background of each 
individual in the study.  While this is critical in candidate gene studies, it is less important in 
large-scale genetic studies because ancestry can be inferred genetically (discussed in the 
following section). In addition to self-report, other extensive questionnaire tools have been 
developed to aid in collecting information about ancestry (Lin & Kelsey, 2000). Analyses could 
then be carried out separately for each ethnic subgroup.  However, self-reported race/ethnicity 
has been criticized for being an inaccurate assessment of genetic ancestry (Race Ethnicity and 
Genetics Working Group, 2005).  Because this inaccuracy can lead to population stratification, 
investigators have advocated the genotyping of ancestry informative markers (AIMs) (Seldin & 
Price, 2008) to more accurately infer individual ancestry. Some studies have suggested that self-
report can be equivalent to genetic ancestry determined by AIMs (Yaeger et al., 2008), but this is 
dependent on the specific markers genotyped as AIMs and the level of detectable substructure 
desired by the investigator.  
 
Statistical methods for detecting and controlling for population stratification 
Although the confounding effects of population stratification can be mitigated by 
carefully choosing a study population, it can rarely be completely eliminated.  Furthermore, the 
confounding effects of population stratification becomes more severe as sample size increases 
(Pritchard & Rosenberg, 1999; Reich & Goldstein, 2001).  Others have shown that even with a 
uniformly European sample of 3000 individuals, differences in genetic variation can be detected 
between populations centered in geographic areas as little as a few hundred kilometers apart 
(Novembre et al., 2008).  Even slight differences in prevalence rates of the outcome of interest 
between these groups could cause spurious associations (McClellan & King, 2010).  To deal with 
these challenges, statistical methodology has been developed and implemented into software to 
aid in detecting and adjusting for population stratification in genetic association studies.  One 
method, genomic control (Devlin & Roeder, 1999; Reich et al., 2001), aims to control for 
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population stratification by first estimating an inflation factor, then adjusting all of the test 
statistics downward by this factor.  Several variations on genomic control have been developed, 
and a recent comprehensive review and critical evaluation of genomic control methods (Dadd, 
Weale, & Lewis, 2009) recommended genomic control F (GCF) (Devlin, Bacanu, & Roeder, 2004) 
as the most appropriate variation.  GCF does not assume the inflation factor is measured without 
error, and refines this factor accordingly.  Structured association (Pritchard, Stephens, & 
Donnelly, 2000), implemented in the STRUCTURE software (2009b), uses genotype data to infer 
population structure, and then performs tests of association within each inferred subpopulation.  
Investigators may also use STRUCTURE to identify individual samples that do not cluster with 
the majority of the samples. These samples may then be eliminated from the analysis.  Because 
the risk of confounding by population stratification increases with sample size (Marchini et al., 
2004), and because extremely large sample GWAS are becoming increasingly common, another 
method has been developed that utilizes large samples and thousands of markers throughout the 
genome to correct for population structure.  Eigenstrat (Price et al., 2006; Patterson, Price, & 
Reich, 2006) uses principal components analysis (PCA) to explicitly detect and correct for 
population stratification on a genome-wide scale in large sample sizes in a computationally 
efficient manner.  Eigenstrat was first described for case-control analysis but can be used for 
quantitative trait outcomes as well.  EIGENSOFT is freely available open-source software for 
conducting Eigenstrat analyses, available online (2009a). A recent report using large-scale 
simulation studies to compare methods for correcting for population stratification examined all 
of the above-mentioned techniques, and found that PCA-based methods (as implemented in 
Eigensoft) outperformed both genomic control and structured association in terms of maximizing 
power, controlling type I error, maintaining in computational efficiency (Zhang, Wang, & Deng, 
2008b). 
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Traditional statistical methods for genetic association analysis 
 
Traditionally, the analysis of genetic factors that contribute to quantitative traits involves 
testing each marker individually for association to the phenotype.  When the outcome of interest 
is a categorical trait or event, traditional analytical methods test for allele or genotype frequency 
differences between cases and controls. When the outcome is continuous, traditional approaches 
test for significant differences in the mean of the outcome of interest across different genotype 
classes at a given locus.  Below, I outline several traditional statistical approaches for genetic 
association analysis when the outcome of interest varies continuously. I will discuss their 
strengths and weaknesses, where to find software implementations that make them accessible, 
and examples of how these techniques have been used in the analysis of genetic association data. 
 
ANOVA 
The analysis of variance (ANOVA) tests for significant differences in the mean value of a 
quantitative outcome between individuals in groups based on genotype.  The theoretical 
justification of ANOVA has been demonstrated in numerous statistical texts (Maxwell & 
Delaney, 2004; Sokal & Rohlf, 1995), and its implementation is widely available in nearly every 
statistical computing software.  ANOVA has a clear interpretation, and when its assumptions are 
met, it is uniformly the most powerful statistical procedure for detecting differences in a 
continuous outcome between groups. ANOVA also allows very specific hypotheses to be tested 
using linear contrasts, for example, testing the hypothesis that the homozygote for the minor 
allele has a decreased plasma concentration of high density lipoprotein when compared to 
individuals of both other genotypes. 
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Linear regression  
Linear regression is a generalization of the analysis of variance - any analysis that can be 
performed in ANOVA can be performed equivalently in linear regression.  Using the linear 
regression framework, a model can be fitted to test any specified mode of inheritance (dominant, 
additive, recessive).  Linear regression also allows other clinical, genetic, or environmental 
components to be taken into account, or adjusted for, when assessing the unique effect of a 
genetic variant.  Furthermore, linear regression allows very specific tests for both gene-gene and 
gene-environment interaction - a topic that I discuss at length later in this chapter.  While adding 
more predictor variables and interaction terms to a regression equation will always improve the 
model fit, care should be taken to choose a model that has the added advantage of parsimony.  A 
commonly used measure for aiding in model selection is the Akaike Information Criterion (AIC), 
which gauges how closely the predicted values fit the actual values, with a penalty for each 
predictor variable added to the model (Agresti, 1990).  Once a well-fitting model has been 
developed, the linear regression equation can be used as a prediction equation for the value of 
the quantitative trait of interest as a function of genetic variants or other variables present in the 
equation.  It is important, however, that the predictive ability of a model be tested in an 
independent dataset.  In addition to being standard with almost any statistical computing 
software, linear regression is also available in PLINK (Purcell et al., 2007), an open-source 
software tailored specifically for the analysis of genetic data, freely available online (2009f). 
 
Non-parametric or distribution-free methods   
The analysis of variance and linear regression both have a very similar set of assumptions 
about the underlying distribution of data points that must hold for their estimates and standard 
errors to remain unbiased (Maxwell et al., 2004), namely that the outcome must follow a normal 
(Gaussian) distribution, and the variance of the outcome must be equal across groups with 
different genotypes (Maxwell et al., 2004; Sokal et al., 1995).  Many quantitative traits often do not 
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strictly adhere to these assumptions, often times being skewed, lognormal, or exponentially 
distributed (Kathiresan et al., 2009), or having a variance that differs dramatically across groups 
of subjects with different genotypes (Mushiroda et al., 2006).  While the above methods are robust 
to small violations of these assumptions, substantial violations may warrant the use of non-
parametric, or distribution-free methods.  The Kruskal-Wallis procedure (Sokal et al., 1995) is a 
non-parametric alternative to ANOVA for testing differences in group means.  The Kruskal-
Wallis procedure and methods similar to it usually rely on rank statistics.  While the Kruskal-
Wallis procedure is robust to violations of the assumptions of ANOVA, it is not as powerful as 
ANOVA when its assumptions hold.  The Kruskal-Wallis procedure is available in most 
statistical computing software, including the freely available open-source R statistical computing 
language (R Development Core Team, 2005). 
All of the above-mentioned procedures share a feature in common: regardless of which 
of these is used, most analyses in GWA studies on quantitative outcomes test for differences in 
the average value of the trait between genotype groups one SNP at a time.  Below I discuss the 
importance of gene-gene and gene-environment interaction, and recent developments for 
optimizing statistical analysis in genetic association studies that go beyond the traditional one-at-
a-time approach that is most commonly used. 
 
Rare Variation and Epistasis 
 
Despite the dizzying pace of advances in genotyping technologies that have made GWAS 
accessible, we have not been able to fully take advantage of the wealth of data generated by these 
studies because our analytical strategies have not kept pace.  As mentioned previously, the most 
commonly used analytical procedures for analyzing GWAS data are tests of association at a 
single genetic variant at a time.  This approach has been arguably successful in identifying 
genetic variants associated with complex traits(McClellan et al., 2010; Goldstein, 2009; 
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Hirschhorn, 2009; Kraft & Hunter, 2009), but these variants collectively explain little of the 
genetic component expected based on family and twin studies (Maher, 2008; Manolio, 2010).   
 
One potential explanation for this is the fact that current GWAS techniques are largely 
based on the "common disease common variant" (CDCV) hypothesis, which is largely 
unsupported by empirical evidence (Iles, 2008; McClellan et al., 2010).  This is because most of 
our richest resource on human genetic variation is limited mostly to common variation 
(International hapmap consortium, 2003; International hapmap consortium, 2007), and because 
current GWAS technology is focused on providing assays for polymorphisms with high 
heterozygosity in populations of European descent.  An alternative or perhaps supplemental 
hypothesis to the CDCV hypothesis is that the missing genetic component to complex traits may 
lie in rare variation, which is by and large not assayed by current GWAS techniques.  Whole-
genome sequencing technologies (Mardis, 2008; Schuster, 2008; Von Bubnoff, 2008; Metzker, 
2010) are being developed as of this writing that will allow for inexpensive examination of rare 
variation within the next year. 
 
In addition to rare variation, many investigators have speculated that the missing genetic 
component lies in gene-gene and gene-environment interactions (Maher, 2008; Manolio, 2010).  
Indeed, it is generally accepted that common traits are complex, and are influenced by an 
intricate interplay of multiple genetic and environmental exposure (Lander & Schork, 1994; 
Moore & Williams, 2002; Moore & Williams, 2005; Ritchie et al., 2001).  This belief has been 
shared by biologists for over 70 years, when it was first emphasized by Sewall Wright that any 
biological or evolutionary endpoint is dependent on complex interactions between genes and 
environmental factor (Wright, 1932).  It is still thought that gene-gene and gene-environment 
interactions are ubiquitous given the complex biomolecular interactions that are essential for 
regulation of gene expression and complex metabolic network (Gibson, 1996), and are likely to 
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play a role in influencing human traits (Moore, 2003).  Furthermore, while recent perspectives 
have emphasized the fact that most true genetic associations to complex traits carry a vanishingly 
small effect size (Hirschhorn, 2009; Goldstein, 2009; Hardy & Singleton, 2009b; Kraft et al., 2009), 
others have shown experimentally that gene-gene interactions are pervasive and often carry 
surprisingly large effects (Shao et al., 2008; He, Qian, Wang, Li, & Zhang, 2010).  
 
Interactions and Quantitative Outcomes: New Approaches 
 
Compelling evidence makes it clear that epistasis exists in humans and model organisms 
and influences human traits, yet there is no consensus on how to best optimize statistical analysis 
for investigating interactions in genetic association studies.  One approach is to evaluate multi-
marker combinations for potential interactive effects based on biological criteria (Carlson, Eberle, 
Kruglyak, & Nickerson, 2004).  This may include, for instance, testing for interactions between 
genes that share a similar structure or function, or genes in the same pathway or biological 
process, such as a receptor and its ligand.  Using this strategy would bias the analysis in favor of 
models with an established biological foundation in the literature, and novel interactions 
between SNPs would be missed. Furthermore, the entire analysis is conditional upon the quality 
of the biological information used.  Another approach is to select SNPs based on the strength of 
their independent main effects, evaluating interactions only between SNPs that meet a certain 
effect size or significance threshold (Kooperberg & Leblanc, 2008).  This strategy assumes that 
relevant interactions occur only between markers that independently have some major effect on 
the phenotype alone. This assumption is neither biologically nor statistically well-grounded.  
Biologically, compensatory mechanisms and redundancy at other loci can mitigate the effects of a 
devastating mutation or polymorphism at another locus, thus rendering its effect undetectable.  
This is evident in the many gene knockout mouse lines that show no apparent phenotype (Baba, 
Azuma, Kashiwabara, & Toyoda, 1994; Colucci-Guyon et al., 1994; Gorry et al., 1994; Gruda et al., 
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1996; Itohara et al., 1993; Killeen, Stuart, & Littman, 1992; Kneitz, Herrmann, Yonehara, & 
Schimpl, 1995; Zheng et al., 1996).  Statistically, main effect components and interactions between 
them are mathematically independent effects (Maxwell et al., 2004).  Furthermore, theoretical 
studies have shown that traits can be influenced exclusively through the interaction of two or 
more genetic variants (Culverhouse, Suarez, Lin, & Reich, 2002; Moore, Hahn, Ritchie, Thornton, 
& White, 2002), and filtering based on significant main effects would miss these types of 
discoveries. 
 
Exhaustive Evaluation 
A strategy to search for a gene-gene or gene-environment interaction that influences a 
complex trait without preconditioning on single SNP main effects is to exhaustively evaluate the 
relationship between the phenotypic outcome of interest and every possible combination of 
genetic and environmental exposures.  While one may wish to fit ANOVA or linear regression 
models to every possible 2-, 3-, or n-way combination SNPs, this approach becomes problematic 
for several reasons.  First, when interactions among multiple genetic and/or environmental 
components are considered, there are many combinations that are present in only a few 
individuals or perhaps none at all.  This is known as the curse of dimensionality (Bellman, 1961), 
and results in unstable estimates of population parameters from large-sample based methods 
such as ANOVA and linear regression.  Furthermore, while the interpretation of the statistical 
significance of models fit using traditional methods is fairly straightforward, correction must be 
made for multiple testing.  Tests of interactions are large in number, and are not independent, 
each making multiple testing correction difficult.  Also, as mentioned before, these methods are 
uniformly the most powerful technique for detecting differences in the mean value of an 
outcome, but this only holds when all assumptions are met.  For many genetic studies of complex 
diseases, however, these assumptions are typically violated to some degree.  Finally, these 
methods are typically the most efficient only when a mode of inheritance is specified (e.g. 
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dominant, recessive, additive, etc).  One of the first methods proposed that would obviate some 
of these issues is the combinatorial partitioning method (CPM) (Nelson, Kardia, & Sing, 2000).  
CPM works by expanding multilocus genotype combinations and then partitioning these 
genotypes into groups that explain the largest proportion of variance in the quantitative trait 
outcome.  A later improvement on this method was the restricted partitioning method (RPM) 
(Culverhouse, Klein, & Shannon, 2004), which does not spend valuable computing resources 
evaluating multilocus genotype partitions that explain little variance.  A third similar approach is 
the generalized Multifactor Dimensionality Reduction (gMDR) (Lou et al., 2007), a variation on 
the widely used MDR case-control framework (Ritchie et al., 2001; Ritchie & Motsinger, 2005).  
An advantage of exhaustive approaches like CPM, RPM, and gMDR is that they will search 
through every possible multivariable model for a given dimensionality to find the optimal set of 
genes and environmental factors to most accurately model a quantitative outcome.  These 
methods will report an optimal set of genes found and the amount of variance in the outcome 
explained by partitioning multilocus genotypes at these genes.  As with any data mining 
technique however, care must be taken to avoid overfitting (Bishop, 2006), or "memorizing" each 
data point, rather than discovering the true underlying model.  Cross-validation (Hastie, 
Tibshirani, & Friedman, 2001) is a widely employed and easily implemented technique for 
mitigating the risk of overfitting a model to a particular dataset.  Furthermore, while the 
theoretical sampling distribution of test statistics for these methods is unknown, statistical 
significance of models discovered with these combinatorial procedures may be empirically 
estimated using permutation testing (Good P., 2000).  Here, the null hypothesis will be 
empirically generated by shuffling the outcome variable values among individuals in the dataset, 
and running the modeling procedure many times, generating a null sampling distribution of the 
statistic reported by these methods (e.g. R²).  The statistic from the unpermuted analysis is 
compared against this null sampling distribution to estimate statistical significance.  Because 
permutation testing requires running the modeling procedure usually thousands of times on 
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permuted data, this can be computationally intensive even in small datasets.  However, one 
group has recently reported a way to approximate permutation testing that requires as little as 
1/50th of the time a full permutation test would require (Pattin et al., 2008). 
Exhaustive approaches such as the ones mentioned above are ideally suited for exploring 
interactions in small genetic datasets comprised of only a few variables, such as in a candidate 
gene study.  However, the computational resources required to exhaustively search for 
interactions in GWAS scale data is often prohibitive.  For example, the number of two-way 
interactions that can be evaluated in a GWAS with 500,000 SNPs is 1.2×1011.  Memory issues 
aside, it would take many years on a desktop computer to run this analysis.  This limitation is the 
motivation for developing techniques that still utilize the full dimensionality of the data without 
exhaustively searching all possible combinations of variables with the goal of discovering a well-
fitting model that explains variance in a complex trait.  Below I discuss three computational 
strategies for discovering gene-gene interactions in large-scale genetic data where an exhaustive 
approach would likely be computationally prohibitive. 
 
Evolutionary Computing 
Sharing many similarities with Darwinian evolution of biological organisms, 
evolutionary computing has been proposed as a way to discover gene-gene and gene-
environment interactions that contribute to a human phenotype (Thornton-Wells, Moore, & 
Haines, 2004).  Individuals in biological populations can be thought of as candidate solutions to a 
problem, where the problem in nature is to survive and reproduce.  Individuals that are more fit 
will be selected, and their genes will be propagated in future generations in the population.  By 
analogy, evolutionary computing commences by defining a population of candidate solutions to 
a problem, where the problem is to find a model containing influential genes that can explain a 
large proportion of variance in the outcome.  "Individuals" are candidate solutions, i.e. 
mathematical models containing genetic and environmental variables attempting to explain 
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variance in the outcome of interest in the study.   The candidate solutions that explain more 
variance in the outcome are the models that contain combinations of variables that truly influence 
the phenotype, and these models are selected and reproduced in subsequent generations of 
evolutionary computing.  In addition, after this phase of selecting the "most fit" individuals, 
models may be "mutated" (switching one genetic variant out for another in the dataset), or 
undergo "recombination" with another well-fitting model.  Evolutionary computing can be 
thought of as a pattern recognition, or machine learning approach for discovering complex 
genetic models that influence a trait.  Evolutionary computing has been used extensively in other 
disciplines to model complex processes (Hung & Adeli, 1994; Lee, 1996; Likartsis, Vlachavas, & 
Tsoukalas, 1997; Yang, Kao, & Horng, 1996; Zhang, Sankai, & Ohta, 1995; Belew, McInerney, & 
Schraudolph, 1990; Chen & O'Connell, 1997; Topchy & Lebedko, 1997; Cantu-Paz & Kamath, 
2008; Skinner & Broughton, 1995; Yan, Zhu, & Hu, 1997).  In addition to using evolutionary 
computing for genetic association studies (Motsinger, Lee, Mellick, & Ritchie, 2006; Motsinger, 
Dudek, Hahn, & Ritchie, 2006; Motsinger, Reif, Dudek, & Ritchie, 2006; Motsinger, Reif, Fanelli, 
Davis, & Ritchie, 2007; Motsinger-Reif, Dudek, Hahn, & Ritchie, 2008; Motsinger-Reif, Fanelli, 
Davis, & Ritchie, 2008; Ritchie, White, Parker, Hahn, & Moore, 2003; Ritchie & Coffey, 2004), 
evolutionary computing has been used in other biological applications including microarray 
analysis (Huang, Liu, & Xu, 2008), cancer classification (Mukhopadhyay, Maulik, & 
Bandyopadhyay, 2009), molecular docking (Tavares, Mesmoudi, & Talbi, 2009), and protein 
folding (Vullo, Passerini, Frasconi, Costa, & Pollastri, 2008).  A team of leaders in the field have 
recently prepared a book (Poli, Langdon, & McPhee, 2008), giving an overview of genetic 
programming (a widely used type of evolutionary computing), available online (2009c).  
 
Candidate Epistasis  
Another recently described strategy, the Biofilter (Bush, Dudek, & Ritchie, 2009), 
combines a bioinformatics approach with traditional statistical hypothesis testing.  Several years 
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ago, when the genome was too large to fully interrogate with genotyping, disease gene mapping 
investigators relied on the candidate gene study design.  Here, candidates were selected for 
genotyping based on their hypothesized biological function, and statistical tests were carried out 
on a SNP-by-SNP basis, as described previously.  Now, with the advent of GWAS and the 
impending arrival of inexpensive whole-genome sequencing, assaying human variation across 
the entire genome is no longer the issue it was in the past.  While millions of SNPs can be tested 
one-by-one for association to a trait, the interactome is too large for us to fully investigate, as 
described above.  The approach taken in (Bush et al., 2009) reduces the interaction search space 
by assessing specific combinations of genetic variants based on prior statistical and biological 
knowledge.  The method creates multi-SNP models based on information from publicly available 
bioinformatics data sources that can then be straightforwardly tested using logistic or linear 
regression.   
 
Expert Knowledge guided Evolutionary Computation.   
Finally, there is much interest in the computer science community to develop strategies 
for incorporating expert knowledge into evolutionary computation (Moore & White, 2007).  As 
mentioned above, it is theoretically possible and likely in some cases that a trait is influenced 
exclusively by the interaction two or more genetic variants, with neither genetic variant having a 
main effect by itself.  This represents the worst-case scenario for an evolutionary method.  In fact, 
it has been shown that evolutionary methods perform little better than randomly testing models 
for association with the outcome when the underlying model is purely epistatic (White, Gilbert, 
Reif, & Moore, 2005).  However, supplementing an evolutionary procedure with expert 
knowledge has been shown to increase the statistical sensitivity of evolutionary methods for 
finding these difficult-to-model interactions (Moore, Barney, & White, 2008; Greene, White, & 
Moore, 2007; Greene, White, & Moore, 2009).  In these reports, the authors used a data-driven 
approach, relying upon prior statistical expert knowledge as a result of preprocessing the data.  
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The notion presented in (Bush et al., 2009) suggests a different approach, where expert 
knowledge is gleaned extrinsically, without any data analysis or preprocessing.  Here, multi-gene 
groupings were created based on representation in publicly accessible biological databases, such 
as the Gene Ontology (Ashburner et al., 2000), or Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (Kanehisa & Goto, 2000).  Multi-SNP models in from these gene groupings were then 
prioritized in analysis.  A very promising approach involves combining a bioinformatics 
approach such as this with evolutionary computation, allowing investigators to take advantage 
of the many decades of biomedical research to guide a machine learning procedure.  
Furthermore, while the above-mentioned bioinformatics approach is gene-centric, incorporation 
of these principles into a stochastic evolutionary procedure would allow for discovery of gene-
gene interactions between genetic variants that may not be in gene regions (e.g. an interaction 
between variants in a micro-RNA and its target).  This is the motivation for incorporating domain 
knowledge into grammatical evolution for discovering multi-locus genetic models that influence 
quantitative traits, as described in Chapter II. 
 
Conclusions 
 
I have presented here study design strategies and statistical methodologies for 
optimizing statistical analysis in genetic association studies.  Careful consideration of the 
phenotype under study, the population in which the study is carried out, and the procedures 
used to model genetic influences are all equally important for achieving maximum statistical 
power and breadth of interpretation.  Irrespective of the above-mentioned considerations, one of 
the most important aspects of genetic association studies is replication in an independent sample 
and/or functional studies.  The NCI-NHGRI Working Group on Replication in Association 
Studies recently established recommendations for bona fide replication of GWAS result (Chanock 
et al., 2007a).  Basic conditions for a successful replication include a sufficient sample size to 
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replicate the genetic effect size estimated in the discovery dataset, an independent replication set, 
the same outcome phenotype for both data sets, a similar study population, similar direction of 
effect from the same SNP or a SNP in near perfect LD, a consistent genetic model, and adequate 
reporting of replication study design and analysis.  Replication of a multi-SNP model presents 
new challenges, and how to effectively test for replication of higher-order models remains an 
open question in the field of human genetic epidemiology. 
Several years have elapsed since the advent of genome-wide association studies, bringing 
several success stories as well as many disappointments.  We must ensure that our strength in 
study design and optimal statistical methodology keeps pace with the relentless progression of 
genotyping and sequencing technology so that we may reap the benefits of the wealth of data we 
will soon face.  A characteristic that most bleeding-edge statistical methodologies have in 
common is that they often abandon the simple approach of considering one genetic variant in 
isolation when modeling the etiology of complex phenotypes.  Methods exploiting existing 
domain knowledge are likely one of many solutions required for the challenging task of properly 
mining large genomic datasets to identify all variation having an impact on human health. 
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CHAPTER II 
 
ATHENA: A KNOWLEDGE-BASED HYBRID BACKPROPAGATION-
GRAMMATICAL EVOLUTION NEURAL NETWORK ALGORITHM FOR 
DISCOVERING EPISTASIS AMONG QUANTITATIVE TRAIT LOCI2 
 
Introduction 
 
Genome-Wide Association Studies and Epistasis 
As discussed in Chapter I, the genome-wide association study (GWAS) is a widely used 
technique in human genetics research to investigate DNA variations associated with common 
human diseases. Modern genotyping technology allows us to quickly and inexpensively assay 
millions of SNPs, but our analytical strategies have not kept pace with technological advances in 
the genotyping lab.  The most commonly used analytical procedures for analyzing GWAS data 
are straightforward tests of association examining one SNP at a time.  This approach has been 
somewhat successful in identifying genetic variants associated with complex traits, including 
age-related macular degeneration (Klein et al., 2005), type II diabetes (Frayling, 2007), 
hypertension (Newton-Cheh et al., 2009), and blood cholesterol levels (Kathiresan et al., 2009; 
Willer et al., 2008b), among others (Hindorff et al., 2009; Johnson & O'Donnell, 2009).  With the 
possible exception of the CFH gene in AMD, however, these single SNPs collectively explain little 
of the genetic contribution to the trait variance that is expected based on family and twin studies 
(Maher, 2008; Goldstein, 2009).  For instance, HDL-cholesterol level is highly under genetic 
control - up to 73% of variation in HDL can be explained by genetic factors (Pietilainen et al., 
2009) - yet even the largest GWAS meta-analysis to date with over 100,000 samples found that 
                                                     
2
 Adapted in part from a series of three peer-reviewed articles on the method: [1] Turner, S. D., Dudek, S. 
M., & Ritchie, M. D, (2010), "Grammatical Evolution of Neural Networks for Discovering Epistasis among 
Quantitative Trait Loci," Lecture Notes in Computer Science, 6023, 86-97; [2] Turner, S. D., Dudek, S. M., 
& Ritchie, M. D, (2010), "Incorporating Domain Knowledge into Evolutionary Computing for Discovering 
Gene-Gene Interaction," Lecture Notes in Computer Science, 6238(I), 394-403; and [3] Turner, S. D., 
Dudek, S. M., & Ritchie, M. D, (2010), "ATHENA: A Knowledge-Based Hybrid Backpropagation-
Grammatical Evolution Neural Network Algorithm for Discovering Epistasis among Quantitative Trait 
Loci," BioData Mining, 3:5. 
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collectively only ~12% of this variance could be accounted for by the additive effects of 58 highly 
significant single-SNPs (Teslovich et al., 2010). Many agree that a portion of this "missing 
heritability" likely lies in gene-gene and gene-environment interactions (Cordell, 2009; Maher, 
2008; Manolio et al., 2009).   
 
Grammatical Evolution Neural Networks (GENN) and Domain Knowledge: ATHENA 
Neural networks (NNs) are a robust and flexible modelling technique that attempt to 
mimic the basic structure and function of biological neurons to solve complex problems.  NNs 
have been applied to many research fields, including robotics, speech recognition, optical 
character recognition, task scheduling, and industrial processing among many others.  NNs have 
also been widely applied to various problems in biological science, including microarray data 
analysis (Linder, Richards, & Wagner, 2007), genotype calling (Huang et al., 2004; Shen et al., 
2005), human linkage analysis (Lucek, Hanke, Reich, Solla, & Ott, 1998), genetic association 
studies (Ott, 2001), medical expert systems (Porter & Crawford, 2003), survival analysis (Sato et 
al., 2005), and protein folding (Meiler & Baker, 2003). The conventional approach for applying 
NNs to a classification problem is to specify a network architecture, select which variables (SNPs) 
are included as inputs to the network, and fit network weights using a gradient-descent based 
approach such as backpropagation (BP) (Bishop, 1995).  While BP is capable of quickly fine-
tuning weights in a NN, variable selection and modelling are goals which cannot be 
accomplished using this traditional approach. Recently, numerous evolutionary search strategies 
have been applied to NN classification problems to reduce the issues associated with the 
traditional NN approach (Yao, 1999). Using evolutionary computing to model complex processes 
was discussed briefly in Chapter I.  Genetic Programming Neural Networks (Ritchie et al., 2004) 
and Grammatical Evolution Neural Networks (GENN) (Motsinger-Reif et al., 2008) use genetic 
programming (Koza & Rice, 1991) or grammatical evolution (GE) (O'Neil & Ryan, 2003) to evolve 
populations of neural networks for human genetics classification problems.  These populations 
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are a heterogeneous mix of architectures, weights, and input variables that undergo mating, 
crossover, and recombination to ultimately identify an optimum NN solution, simultaneously 
finding influential SNPs and fitting networks weights.  We have furthermore recently shown that 
certain features characteristic of human genetic data (linkage disequilibrium) may provide 
advantages to methods that evolve NNs to detect gene-gene interactions by transforming the 
fitness landscape from a "needle in a haystack" to a broader, smoother surface (Turner, Ritchie, & 
Bush, 2009). 
The application of GE to find epistatic gene-gene interactions is still exceedingly difficult, 
especially when the underlying disease model is purely epistatic, where each variant has no 
independent effect on the phenotype (White et al., 2005).  After demonstrating the critical need 
for expert knowledge when applying genetic programming to GWAS (Moore et al., 2007), others 
have shown that using expert knowledge guided mutation, selection, and crossover is highly 
beneficial, and dramatically improves the performance of evolutionary algorithms (Moore et al., 
2008; Greene et al., 2007).  In much of the previous work showing that expert knowledge 
increases the performance of natural computing algorithms for finding epistatically interacting 
SNPs, the statistical expert knowledge was gleaned intrinsically - typically using a data-driven 
approach using variants of the Relief algorithm for feature selection (Greene et al., 2007; Moore, 
Andrews, Barney, & White, 2008; Greene, Gilmore, Kiralis, Andrews, & Moore, 2009). 
Here we extend our previous work with NN training (Turner, Dudek, & Ritchie, 2010b) 
to evaluate several fundamental modifications to the algorithm in a new tool, ATHENA (the 
Analysis Tool for Heritable and Environmental Network Associations).  First, we implemented 
an alternative tree-based GE crossover strategy as previously described (Motsinger, Hahn, 
Dudek, Ryckman, & Ritchie, 2006; Turner et al., 2010b).  A potential weakness of GE is the 
destructive single-point binary crossover (SPBXO) operator (O'Neil et al., 2003).  Tree-based 
crossover (TBXO) instead swaps functionally analogous branches by first translating the 
grammar into functional neural network trees, identifying branches with identical root nodes, 
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then initializing a crossover back at the genome level that would correspond to the crossover 
between the whole branches.  This renders GE to be much more like genetic programming (GP), 
while still maintaining some of the key advantages of GE. We also evaluate the performance 
improvement when we combine GE with the traditional approach of fitting network weights 
with backpropagation.  Finally, we evaluate with simulation whether utilizing available 
biological domain knowledge gleaned extrinsically would increase ATHENA’s performance in 
discovering epistatic interactions between genetic variants contributing to a quantitative trait 
outcome. Here we present results of a simulation study showing that (1) using an alternative 
crossover strategy (TBXO) results in a considerable performance increase in some scenarios, (2) a 
hybrid backpropagation-GENN training algorithm has better performance than GE alone, and (3) 
incorporating biological knowledge from external sources results in an increase in ATHENA’s 
ability to detect and model gene-gene interactions among a large pool of unassociated noise 
variables. 
 
Methods 
 
Genetic data simulation with genomeSIMLA 
Simulated data where the true identity and size of the genetic or environmental effect in 
the population is known is a necessity for developing and testing novel methodology.  It is also 
important that these true effects are embedded in a dataset containing many other nonfunctional 
polymorphisms and environmental factors, as is the case when real genetic data is collected.  We 
developed genomeSIMLA (Edwards et al., 2008) for simulating genome-wide scale data in 
population based case-control samples with a categorical outcome.  Here we use an extension of 
genomeSIMLA capable of simulating gene-gene interactions in the presence of main effects, all of 
which influence a quantitative trait at a desired effect size (Turner et al., 2010b). The 
genomeSIMLA source code and binaries can be downloaded freely online (2009d). 
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Whereas the common measure of effect size in genetic association studies employing a 
case-control design is the odds ratio, studies of continuously distributed outcomes, such as HDL 
cholesterol level, estimate effect size as the proportion of variance explained (Willer et al., 2008b; 
Boerwinkle & Sing, 1986), or R². This variance explained, or heritability, can be further divided 
into genetic and nongenetic components, and the genetic component can be further divided into 
additive, dominant, and epistatic variance components (Abney, McPeek, & Ober, 2001).  The 
variance component explained uniquely by a single source of genetic variation (e.g. the main 
effect of one member of an interacting pair of variants, or the epistatic effect of the interaction 
term) is given by the semi-partial squared correlation coefficient (Cohen, Cohen, West, & Aiken, 
2002): 
 
1 2 1 2
2 2 2
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sr R R 
 
 
The first term on the right side of the equation is the overall variance explained by fitting 
a full model (regressing the outcome, y, on each main effect and the interaction term between 
them. The second term on the right-hand side is the proportion of variance explained by the 
model when a predictor variable of interest is omitted from the model – for instance, omitting the 
interaction term. The difference between these two quantities is the semi-partial squared 
correlation coefficient (Cohen et al., 2002), and describes the unique impact on the phenotype, y, 
for the particular variance component, xi. These estimates do not take into account the bias 
corrections discussed by Boerwinkle and Sing (Boerwinkle et al., 1986). As these investigators 
showed, the bias in these estimators for the number of genotype classes represented here quickly 
approaches zero as sample size increases past n=100. Since our simulated datasets comprise 2000 
samples, the bias discussed by these investigators is essentially zero. 
Datasets were simulated as previously described (Turner et al., 2010b): Samples are 
drawn from a homoscedastic normal distribution with the mean being determined by the 
31 
 
genotypes at the corresponding functional genetic variants. We simulated 500 SNPs in 2000 
samples, where only two SNPs were functional and the other 498 SNPs were unassociated "noise" 
variables.  We simulated a gene-gene interaction between these two SNPs that carried a narrow-
sense heritability (h²) of 0.05, meaning that only 5% of the variation in the quantitative trait could 
be explained by this gene-gene interaction.  We simulated this interaction in the context of very 
small main effects at each locus (h²=0.01).  This low effect size is typical of most findings in 
human genetic epidemiology (Hirschhorn, 2009; Goldstein, 2009). Both main effects and the gene-
gene interaction were additive.  A scenario such as this where main effects explain little of the 
overall outcome variance represents a very difficult problem (Freitas, 2001) for an evolutionary 
search procedure to model. 
 
Domain knowledge 
A recently developed tool called Biofilter is capable of integrating information from 
several publicly available biological databases to assess specific combinations of genetic 
variations and their effect on the outcome based on prior statistical and biological knowledge 
(Bush et al., 2009).  Specifically, this tool uses the Gene Ontology (Ashburner et al., 2000), the 
Database of Interacting Proteins (Xenarios et al., 2002), the Protein Families Database (Bateman et 
al., 2004; Finn et al., 2008), the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et 
al., 2000), Reactome (Vastrik et al., 2007), NetPath (2008b), and the Genetic Association Database 
(GAD) (Becker, Barnes, Bright, & Wang, 2004) to construct two-SNP models that are supported 
by the biological literature. Their degree of support in the literature is characterized by an 
implication index - which is a count of how many times a relationship between a pair of two 
genes appears across multiple databases incorporated into Biofilter.  
To determine whether incorporation of domain knowledge into NN training in 
ATHENA can improve its performance, simulated domain knowledge that mimics information 
obtained from Biofilter must be generated. Here, 4000 random undirected edges are drawn 
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between a subset of the 500 SNPs simulated as described above. The implication index is the 
number of edges drawn between two models. This number typically ranges from 0 to 5, where 
implication index of zero indicates no support in the simulated knowledge pool, while an 
implication score of 5 indicates that this model is very well supported.  The implication index 
corresponding to the functional two-SNP model where the true effect was embedded could be 
manually specified. Our specific goals were to determine if and to what degree ATHENA's 
performance would diminish if irrelevant domain knowledge were incorporated, and if and to 
what degree ATHENA’s performance would increase if accurate domain knowledge were 
incorporated into the training process. 
 
Alternative crossover, backpropagation, and incorporation of domain knowledge in ATHENA 
NN training in ATHENA has been implemented as previously described (Motsinger-Reif 
et al., 2008; Turner et al., 2010b).  Briefly, grammatical evolution (GE) is a variation of genetic 
programming (GP), an evolutionary algorithm originally proposed by Koza as a procedure to 
optimize NN architecture (Koza et al., 1991).  In GE, randomly initialized binary strings are 
transcribed into an ordered list of integers that are used to select from production rules in a 
Backus-Naur form grammar. Our grammar applies GE to construct neural networks, and can 
simultaneously select important predictor variables and optimize network weights and 
architecture.  We also implemented an alternative tree-based GE crossover strategy as previously 
described (Motsinger et al., 2006; Turner et al., 2010b).  A potential weakness of GE is the 
destructive single-point binary crossover (SPBXO) operator (O'Neil et al., 2003).  Tree-based 
crossover (TBXO) instead swaps functionally analogous branches by first translating the 
grammar into functional neural network trees, identifying branches with identical root nodes, 
then initializing a crossover back at the genome level which would correspond to the crossover 
between the whole branches.  This renders GE to be much more like genetic programming (GP), 
while still maintaining some of the key advantages of GE. Representative NNs produced by GE, 
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and the TBXO process are shown in Figure 2, under the “TBXO” panel. The NNs in this figure 
have either two or three inputs, corresponding to numerically coded values (-1, 0, 1) for SNP 
genotypes (Holzinger et al., 2010). A weight vector corresponds to each layer of weights in the 
NN. In TBXO, functionally analogous branches are crossed over, indicated by the asterisk, 
resulting in a 2-2-1 neural network (Sprinkhuizen-Kuyper & Boers, 1998) with SNPs 1 and 2 as 
inputs. If SNPs 1 and 2 are the functional SNPs responsible for the gene-gene interaction and if 
the weight vectors on this NN are favorable, then this NN should be capable of modelling a gene-
gene interaction between these two SNPs. 
In the first set of experiments, ATHENA was run for 100, 200, and 400 generations, in 
runs consisting of population sizes 100, 200 and 400, in each of 10 demes (populations), for a total 
NN population size of 1000, 2000, and 4000 respectively, on 100 simulated datasets.  We varied 
the number of generations where tree-based crossover was used (TBXO).  This could range from 
using single-point binary crossover (SPBXO) for every generation (i.e. no TBXO), TBXO for the 
first half of the total number of generations before switching back to SPBXO, or TBXO for the 
total number of generations run.  This resulted in trials using 54 different combinations of 
ATHENA parameters, comprising 5,400 in silico datasets.  The mean runtime per dataset was 
approximately 14 minutes spread across five 1.8 GHz Opteron PCs.  The respective probability of 
a crossover and mutation were 0.9 and 0.01, typical values for these parameters in many genetic 
algorithms (Poli et al., 2008).  Addition was the only production rule available for the arithmetic 
operator at each activation node, as described previously (Holzinger et al., 2010; Turner et al., 
2010b). Both grammars are shown in Table 1. This allowed for the implementation and optional 
usage of backpropagation (BP), a local fitting procedure designed to optimize the weights in a 
neural network (Bishop, 1995).  BP was either not used at all, or used at initialization and again at 
generations 100 and 200, using a learning rate of 0.3. BP was halted after either a maximum of 100 
epochs (iterations) had been run, or when further BP showed no improvement (mean squared  
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Figure 2. ATHENA algorithm. The ATHENA algorithm begins by optionally accepting a list of SNP-
SNP models which are derived from biological knowledge sources. This domain knowledge is used to 
initialize a proportion of the NN population. BP is used to optimize the initial weights. After a round of 
selection, GE is used to simultaneously optimize variable selection, NN architecture, and weights. Another 
round of BP takes place midway through training, and at the end of training. Crossover can occur via single 
point binary (SPBXO) or tree-based crossover (TBXO). In SPBXO, crossover occurs at the binary string 
level, but in TBXO, NNs are first translated, and crossover occurs at the binary genome level that results in 
a crossover at functionally similar root nodes. The NNs in this figure have either two or three inputs, 
corresponding to numerically coded values (-1, 0, 1) for SNP genotypes. A weight vector corresponds to 
each layer of weights in the NN. In TBXO, functionally analogous branches are crossed over, indicated by 
the asterisk, resulting in a 2-2-1 neural network with SNPs 1 and 2 as inputs. If SNPs 1 and 2 are the 
functional SNPs responsible for the gene-gene interaction and if the weight vectors on this NN are 
favorable, then this NN should be capable of modelling a gene-gene interaction between these two SNPs. 
35 
 
 
 
 
Table 1. GENN Grammars. Abbreviated grammars for neural networks as currently 
implemented with all four arithmetic functions as production rules, and with addition as the only 
production rule.  
Current Grammar Addition only 
<p>      ::= <pn>(<pinput>) 
<pn>     ::= PA 
           | PS 
           | PM 
           | PD 
<pinput> ::=  
<W>(<winput>)<,><W>(<winput>)<,> 
<winput> ::= <cop><,><v> 
           | <cop><,><p> 
<cop>    ::= (<cop><op><cop>) 
           | <Concat>(<num>) 
<Concat> ::= Concat 
<,>      ::= , 
<W>      ::= W 
<op>     ::= + 
           | - 
           | * 
           | / 
<num>    ::=  <dig>1 
           |  <dig>.<dig>3 
           |  .<dig><dig>3 
           |  <dig>.<dig><dig>4 
           |  
<dig><dig>.<dig><dig>5 
<dig>    ::= 0-9 
<v>      ::= G1-G500 
<p>      ::= <pn>(<pinput>) 
<pn>     ::= PA 
 
# Protected addition only fn 
available. 
 
<pinput> ::=  
<W>(<winput>)<,><W>(<winput>)<,> 
<winput> ::= <cop><,><v> 
           | <cop><,><p> 
<cop>    ::= (<cop><op><cop>) 
           | <Concat>(<num>) 
<Concat> ::= Concat 
<,>      ::= , 
<W>      ::= W 
<op>     ::= + 
           | - 
           | * 
           | / 
<num>    ::=  <dig>1 
           |  <dig>.<dig>3 
           |  .<dig><dig>3 
           |  <dig>.<dig><dig>4 
           |  
<dig><dig>.<dig><dig>5 
<dig>    ::= 0-9 
<v>      ::= G1-G00 
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error is reduced by less than 1×10-6), after which the GE process continues. After every network 
had undergone BP, NNs were reverted back to a binary genome by marking blocks of codons 
(integer sequences) corresponding to a weight, which was then replaced with a block containing 
a grammar compatible block that generates the appropriate weight when GE continues after BP. 
In the second set of experiments, domain knowledge was used to perform sensible 
initialization (O'Neil et al., 2003). Rather than initializing a population of NNs randomly, the 
initial generation is partially composed of NNs containing as input variables SNPs that are 
represented in a domain knowledge source.  This source can be two-SNP models supported by 
biological literature derived from Biofilter (Bush et al., 2009) or simulated domain knowledge 
which mimics domain knowledge derived from Biofilter. Part of the population is still initialized 
randomly. Here the proportion of the initial population which is initialized from domain 
knowledge was varied from 0 to 99% in intervals between 1-10%.  Two-SNP models from domain 
knowledge are prioritized for incorporation in the initial generation based upon implication 
index - models with higher implication index are initialized first. The implication index on the 
functional two-SNP model in these experiments ranged from 0 (negative control - all domain 
knowledge incorrect/irrelevant) to 3 (functional two-SNP model is somewhere in the top half of 
the implication index-ranked list of 4000 domain knowledge two-SNP models).  Here, ATHENA 
was run for 200 generations using 10 demes with population sizes of either 50, 100, or 200 
individual NNs. The mean runtime per dataset was approximately 6 minutes spread across five 
1.8 GHz Opteron PCs. As above, probability of a crossover and mutation were 0.9 and 0.01, and 
the production rule for the activation node function was restricted to addition only, which 
allowed for the optional use of backpropagation. In addition to locally fitting weights to improve 
the model fit when NNs are initialized randomly, this hybrid algorithm allows for weight 
optimization in the event that sensible initialization from domain knowledge resulted in the 
inclusion of either of the two functional variables in the initial generation. 
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Results & Discussion 
 
For the in silico studies described above, sensitivity was measured as the proportion of 
datasets out of 100 simulated datasets for each scenario where the best performing neural 
network model contained the two functional SNPs, with no other SNPs in the model, i.e. a perfect 
match (Turner et al., 2010b). For these experiments we were only interested in measuring 
performance in variable selection. Output from a neural network model using SNPs as the only 
inputs are necessarily discrete, as the output is a nonlinear transformation of a weighted sum of 
the inputs. Example neural network models are shown in Table 2. The output of each neural 
network model is the predicted value of the mean of the multilocus genotype. While constructing 
well-fitting models that can predict genotype means reliably is important, here we only assessed 
performance by examining variable selection. The best neural network model for each dataset 
was chosen using the following algorithm.  First, 5-fold cross-validation (CV) was implemented. 
The data is divided into fifths, training initially occurs on four fifths of the data where a best 
model is chosen based on minimizing mean square error. The fit of this model to unseen data was 
tested on the fifth of the data initially left out using the standard coefficient of determination, R².  
This process was repeated for each CV interval, i.e., each 4/5-1/5 split of the data.  At this point 
there are 5 models - one best model from each CV interval.  The model that consistently appears 
most often across CV intervals is chosen as the best overall model for the entire dataset (Moore, 
Parker, Olsen, & Aune, 2002; Ritchie et al., 2001).  In case of a tie (e.g. two different models 
replicated across two CV intervals), the model with the higher R² is chosen as the overall best 
model. 
 
Tree based crossover (TBXO) 
First we wanted to evaluate whether the alternative TBXO strategy described in the 
methods section resulted in increased performance in the context of GE alone or with the hybrid  
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Table 2. Example neural network models. The table below shows two representative neural network 
models that were produced by grammatical evolution, showing both text and graphical representations of 
the same models. PA/PADD=protected addition; W=weight, G=variable number. The first, simpler model 
weights variable number 5 by 1.16, variable number 10 by 1.22, and adds these weighted input variables 
prior to transforming the output with the nonlinear transfer function. The resulting output will be discrete if 
input variables are discrete, as with SNP genotypes. 
Model (text representation) Model (graphical) 
PA( W(1.16,G5), W(1.22,G10),2) 
 
PA( W(1.6,G10), W((0-1.81), PA( 
W(0.45, PA( W((0-0.18),G2), 
W((0.28*0.01),G10),2)), 
W(3.86,G10),2)),2) 
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BP-GE algorithm in ATHENA which also used backpropagation (BP) in addition to GE.  These 
results are summarized in Figure 3. Separate panels show the total number of generations and the 
size of the population in each deme.  Dashed and solid lines show the performance (sensitivity) 
when BP was and was not used, respectively.  The horizontal axis on each panel shows the 
proportion of the total number of generations in which TBXO was used.  These results also show 
that our implementation of TBXO yields a modest yet notable increase in sensitivity, but when BP 
was not used, the performance increase is observed only when TBXO is used exclusively in the 
early generations of training (see the center point in the solid lines in each panel in Figure 3). 
When BP was used in addition to GE to locally fit NN weights, using TBXO for the first half of 
training resulted in increased performance that did not change when TBXO was used throughout 
the rest of training (dashed lines in Figure 3).  This is in contrast to previous work where TBXO 
showed little improvement when the simulated model was an interaction contributing to a 
discrete trait in the complete absence of main effects (Motsinger et al., 2006).  This difference may 
be due to the fact that here we are analyzing a continuous trait with small main effects rather 
than a case-control outcome under a purely epistatic model without main effects. We then 
statistically evaluated this performance increase, summarized in Figure 4. Here, boxplots show 
the distribution of sensitivity across all combinations of generations and population sizes, and P-
values indicate whether there is a statistically significant increase in sensitivity gained by using 
TBXO (one-way analysis of variance). The top panel of Figure 4 shows the combined results from 
using and not using backpropagation. Bottom panel shows the results considering simulations 
using and not using backpropagation independently. This indicates that the benefit from using 
TBXO when concurrently using BP is highly statistically significant, but there is little evidence to 
suggest using TBXO with the standard GE crossover alone results in any appreciable 
performance gains. 
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Figure 3. Sensitivity to detect both functional loci as the best GENN model. Each panel shows 
sensitivity over the proportion of total generations (none, half, all) where tree-based crossover was used 
instead of binary crossover. Solid line shows when GE alone was used to train NNs (no BP). Dashed line 
shows sensitivity when using the hybrid BP-GENN algorithm (see methods).  Individual panels show 
combinations of the total number of generations GENN was run and the population size per deme. 
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Figure 4. Statistical analysis of effectiveness of tree-based crossover. Boxplots show the distribution of 
sensitivity across all combinations of generations run and population sizes (see Figure 1). P-values indicate 
whether there is a statistically significant increase in sensitivity gained by using TBXO (one-way analysis 
of variance). Top panel shows the combined results from using and not using backpropagation. Bottom 
panel shows the results considering simulations using and not using backpropagation independently. 
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These results indicate that when BP is used, GE with TBXO is more efficient at variable 
selection, while GE with normal crossover allows more variation in building architecture and 
fitting weights.  We postulate that TBXO is preserving "building blocks" which are functionally 
useful to the resultant neural network models.  Our simulations contained a modest interaction 
effect (h²=0.05) in the presence of very small main effects (h²=0.01) at each of the interacting 
genetic variants.  These small main effects may provide the building blocks upon which TBXO 
can capitalize.  Syntactic preservation of NN genomes coding for the inclusion of these variables 
in NN models while allowing the full variability and broader search capability of SPBXO in the 
latter generations of evolution appears to be more powerful than using SPBXO or TBXO 
exclusively. Furthermore, recent work has shown that linkage disequilibrium (correlation 
between genetic variants) may provide building blocks to an evolutionary algorithm which 
builds neural networks when the true underlying model is an interactive effect in the complete 
absence of any main effect at each of the two functional variables (Turner et al., 2009).  It is 
expected that the TBXO strategy discussed here may be optimal in this situation as well.  Because 
our TBXO procedure mimics the function of genetic programming (GP), further studies should 
compare this against GP or any hybrid GP-GE NN training algorithm. 
 
Incorporation of domain knowledge 
Next we evaluated whether initializing the NN population with two-SNP models from 
domain knowledge sources resulted in any changes in performance. These results are 
summarized in Figure 5.  The results here show that sensitivity to detect both genetic variants 
contributing to the trait is always higher when BP was used in conjunction with GE, as also 
shown in Figure 3. When the implication index is 0 (i.e. all domain knowledge is irrelevant), the 
sensitivity when using BP decreases substantially as the proportion of the initial population 
initialized from domain knowledge increases (upper left panel of Figure 5, dashed line). This is 
likely due to the fact that as more NN models are initialized from a list of models from irrelevant  
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Figure 5. Sensitivity increases with the proportion initialized from domain knowledge. This figure 
illustrates the sensitivity of GENN to detect both functional SNPs as the proportion of the NN population 
initialized from domain knowledge increases from 0 to 99%. Panels going left to right show the increasing 
implication index of the model that includes both functional variables. Rows of panels show the population 
size per deme. The X-axis in each panel shows the proportion of the initial NN population which was 
seeded with two-SNP models from a domain knowledge source. Solid line shows when GE alone was used 
to train NNs (no BP). Dashed line shows sensitivity when using the hybrid BP-GENN algorithm (see 
methods). Faint horizontal solid and dashed lines show for reference the baseline sensitivity, for GENN and 
BP-GENN, when the population was initialized randomly, i.e. 0% initialized from domain knowledge. This 
figure indicates that sensitivity increases as the proportion of the NN population initialized from domain 
knowledge increases, and the increase is more notable in smaller population sizes. 
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domain knowledge, there is a smaller chance that either of the functional variables can be 
initialized by chance. When the implication index is at least 1 (meaning the functional two-SNP 
model is supported in our domain knowledge), as this proportion increases, sensitivity fluctuates 
around the baseline sensitivity (37%) at random initialization when BP is not used. This is not 
surprising, because even if a NN is initialized containing both functional variables that influence 
the trait, it is unlikely that by chance the NN would have suitable weights and architecture. An 
increase in performance can be seen when BP is then used to optimize the weights in the sensibly 
initialized NNs from relevant domain knowledge (dashed lines in panels in Figure 5 where 
implication index > 0).  Furthermore, as the implication index for the domain knowledge model 
containing the functional variables increases from 1 to 3, this model is more likely to be 
incorporated into NNs in the initial generation. For instance, when the implication index of the 
functional model is 1, approximately 99% of the population must be initialized from domain 
knowledge to see any benefit. When the implication index is 2 or higher, it is very likely that the 
initial generation will contain a NN with the truly functional variables even when only a small 
proportion of the initial population is initialized from domain knowledge. Finally, looking down 
the rows of panels in Figure 5, it is clear that although the overall performance increases as the 
population size increases, as expected, the benefit of utilizing domain knowledge becomes less 
apparent. The benefits gained from utilizing domain knowledge to initialize a population of 
solutions is most apparent when the search space is large relative to the number of candidate 
solutions, as seen in the top right panel (implication=3, population size=50), dashed line. 
These results demonstrate that the sensitivity of using GE to train NNs to find genes with 
a nonlinear influence on a quantitative outcome can be improved by effectively using extrinsic 
domain knowledge in conjunction with local weight fitting by BP. We showed that initializing a 
proportion of the NN population from two-SNP models incorporated from domain knowledge 
when BP is employed to locally optimize the weights in a NN can result in a performance 
improvement in ATHENA’s ability to detect and model SNPs influencing a quantitative trait. The 
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performance increase was most notable when a smaller population size was used. This indicates 
that when the search space is small enough to be searched very thoroughly or exhaustively, using 
domain knowledge is less beneficial than when the search space is very large compared to the 
number of individual solutions being evolved. In this scenario (such is the case in genome-wide 
association studies), using domain knowledge to bias an evolutionary search in favor of 
important features will be critical for acceptable performance. While the benefits of using 
intrinsically obtained statistical expert knowledge (Moore et al., 2008; Greene et al., 2007), have 
not been explored in the ATHENA algorithm, using this framework to initialize an evolutionary 
search for disease genes based on domain knowledge obtained from public biological databases 
is another means to improve the performance of genetic algorithms for selection of important 
SNPs in a model. 
 
Comparison with other methods 
As discussed in Chapter I, other methods are available for probing the effect of gene-gene 
interactions on quantitative phenotypes. One exhaustive approach to testing gene-gene 
interaction among quantitative traits is the restricted partitioning method (RPM)(Culverhouse et 
al., 2004), an improvement over the combinatorial partitioning method (Nelson, Kardia, Ferrell, & 
Sing, 2001). RPM exhaustively evaluates all possible combinations of 2, 3, …, n-way combinations 
of SNPs, restricting the partitioning of each multilocus genotype into subsets that are likely to 
explain the most variation. While RPM should have high power and favorable computational 
performance in small datasets, as with any exhaustive approach to detecting interactions, its 
performance will decrease substantially as the number of SNPs in a dataset approaches that seen 
in genome-wide association studies. In addition to being extremely computationally intensive, 
exhaustive evaluation of all possible SNP-SNP interactions among GWAS data comes with an 
extraordinary loss of power due to the extremely large number of statistical tests being 
performed. Alternatively, parametric linear regression, when assumptions of normality and 
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homoscedasticity are met, is uniformly the most powerful statistical method for ascertaining 
differences in group means (Maxwell et al., 2004; Cohen et al., 2002). In fact, when the functional 
variables are explicitly modelled, linear regression has >80% power to detect the gene-gene 
interaction effects simulated here (n=2000, sr²main=0.01, sr²interaction=0.05), determined using 
standard power calculation techniques for gene-gene interaction (Gauderman, 2002b; 
Gauderman, 2002a).  This regression-based interaction-testing approach has been successfully 
used in a study of 13 SNPs in the APOE gene that influence ApoE protein levels in the blood 
(Hamon et al., 2004). Furthermore, regression models offer a very straightforward interpretation 
compared to NN models, which are often and unfortunately dubbed “black box” models 
(Dayhoff & DeLeo, 2001). However, in addition to the disadvantages discussed in Chapter I 
(curse of dimensionality, assumption violations, computational and multiple testing burdens 
with large datasets) that make exhaustive regression-based approaches impractical, it is also 
difficult to incorporate a priori information into a parametric regression analysis as it has been 
done here. Several knowledge-driven approaches have been applied to prioritize gene-gene 
interaction testing in large datasets (Baranzini et al., 2009; Bush et al., 2009; Peng et al., 2010; 
Ruano et al., 2010). These methods, however, limit statistical tests only to models supported by a 
priori knowledge. By contrast, the method proposed here only initializes a set of candidate 
solutions using domain knowledge – these solutions are then free to mutate and crossover, 
resulting in new and interesting combinations that may not be directly supported by the existing 
domain knowledge.  
 
Conclusions 
 
Here, we simulated a small effect size nonlinear interaction between two SNPs carrying 
minimal main effects and assessed the sensitivity of using GE to evolve NNs for detecting both 
functional SNPs out of a much larger set of unassociated variables.  We showed that (1) using 
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backpropagation, a fast NN weight optimization procedure, significantly improves ATHENA’s 
performance, (2) using an alternative crossover strategy (TBXO) may allow for functional 
preservation of network information, and results in a statistically significant performance 
increase when used early in training in combination with backpropagation, and (3) incorporation 
of biological knowledge from the public domain can substantially improve ATHENA’s 
performance at finding genes that interact to influence a trait.  The general ATHENA algorithm is 
shown schematically in Figure 2. 
Supplementing an evolutionary search using domain knowledge will be critical when 
using evolutionary procedures to find and model the effect of disease genes on complex human 
traits. Natural biological data will likely have many effects which will be enriched in knowledge 
sources, resulting in an improvement of the overall ability to find many members in the collection 
of influential loci.  Genome-wide association studies offer very inexpensive measurement of over 
1 million SNPs per sample. It is clear that there are more fruitful approaches for understanding 
the genetic architecture of common human phenotypes than ignoring the complexity of biology 
by testing single variants in isolation (Moore, Asselbergs, & Williams, 2010a). One of the 
strengths of the method presented here is that if any arbitrarily complex interaction of genetic 
and environmental exposures influences disease risk, a NN can approximate this function 
(Kurkova, 1991), given proper training. These experiments show that using a hybrid BP-GENN 
training algorithm, alternative crossover strategies, and incorporating domain knowledge into 
the search for genes related to disease can aid the variable selection and model fitting process of 
ATHENA. Ongoing efforts to incorporate other machine-learning algorithms, such as symbolic 
regression, into the ATHENA framework may also increase our ability to detect certain types of 
effects resistant to detection by BP-GENN. 
One limitation in the current study is that these experiments make the assumption that 
loci involved in gene-gene interactions contributing to a heritable trait will carry with them some 
small main effect at either variant.  This is a reasonable assumption to make, in that there are few, 
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if any, examples of a consistently replicating, experimentally verified gene-gene interaction in the 
complete absence of main effects contributing to a complex quantitative trait in humans.  Perhaps 
the reason for this, however, is the inadequacy of our methods for finding gene-gene interactions 
in the absence of main effects rather than the absence of such effects altogether. Biologically, 
redundancy and compensatory mechanisms at other loci can mitigate the effects of a devastating 
mutation or polymorphism at another locus, thus rendering its effect undetectable.  This is 
evident in the many gene knockout mouse lines that show no apparent phenotype (Baba et al., 
1994; Colucci-Guyon et al., 1994; Gorry et al., 1994; Gruda et al., 1996; Itohara et al., 1993; Killeen 
et al., 1992).  Statistically, main effect components and interactions between them are 
mathematically independent effects (Maxwell et al., 2004).  Furthermore, theoretical studies have 
shown that traits can be influenced exclusively through the interaction of two or more genetic 
variants (Culverhouse et al., 2002; Moore et al., 2002).  Finally, one group has shown that main 
effects at variants involved in an epistatic interaction are highly dependent on the allele 
frequency in different populations at each locus, which may explain the lack of replication of 
many gene-gene interaction studies which rely on main effects (Penrod, Greene, & Moore, 2008).  
Future studies should aim to assess these and other extensions of ATHENA in their ability to 
detect and model epistatic interactions contributing to a quantitative trait in the absence of main 
effects, and should attempt to apply these methods in a natural biological data analysis.  
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CHAPTER III 
 
MULTIVARIATE ANALYSIS OF REGULATORY SNPS:  
EMPOWERING PERSONAL GENOMICS BY CONSIDERING  
CIS-EPISTASIS AND HETEROGENEITY3 
 
 
Introduction 
 
As discussed in the previous two chapters, epistasis is thought to be an important 
component of complex, multifactorial diseases due to the monumental complexity of biological 
systems (Tyler, Asselbergs, Williams, & Moore, 2009).  Over the past 10 years, a wealth of data 
from model organisms has supported a role for epistasis (Shao et al., 2008; He et al., 2010).  
Furthermore, epistasis is one way to account for the problem of “missing heritability”, where the 
analysis of single SNPs (single nucleotide polymorphisms) has explained very little of the 
heritability estimated from twin and adoption studies for complex traits (Eichler et al., 2010; 
Manolio et al., 2009).  Accounting for interactions among SNPs may explain a larger portion of 
this heritability (Maher, 2008), expanding our understanding of the genomics of human disease 
and personalized medicine.           
One often cited potentially causal mechanism of gene-gene interaction is due to variation 
in multiple genes in similar pathways, protein families, or genes with similar or redundant 
biological function (Aguilar et al., 2010; Costanzo et al., 2010). This generally implies that 
interaction occurs between genes scattered throughout the genome, implying a trans-epistasis 
effect. Several approaches, including the Biofilter approach described in Chapter II, have been 
applied to investigate these effects in genome-wide association studies (Baranzini et al., 2009; 
Bush et al., 2009; Peng et al., 2010; Ruano et al., 2010).   
                                                     
3
 Adapted in part from: Turner, S.D., Bush, W.S. (2011). "Multivariate Analysis of Regulatory SNPs: 
Empowering Personal Genomics by Considering cis-Epistasis and Heterogeneity." Proceedings of the 
Pacific Symposium in Biocomputing. In press. 
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“Epistasis” is often treated as synonymous with “gene-gene interaction” (Moore, 2003). 
Even I use these phrases interchangeably in other chapters in this thesis. The occurrence of 
epistatis, or statistically non-linear interactions (Fisher, 1918), however, need not be restricted to 
variation between distant genes. Epistatic interactions could also occur between genetic variants 
in close proximity that may impact transcriptional regulation. Recent work investigating the 
transcriptome of HapMap-based cell lines has led to the identification of expression quantitative 
trait loci (eQTLs) - genetic variants that influence the expression of a gene (Pickrell et al., 2010; 
Veyrieras et al., 2008).  Veyrieras et al. published an analysis of gene expression for 11,446 genes 
from HapMap-based lymphoblastoid cell lines (Stranger et al., 2007) leveraging genotypes for 
roughly 3 million single nucleotide polymorphisms (SNPs) to identify eQTL SNPs in a 500 
kilobase (kb) window both upstream of the transcription start site and downstream of the 
transcription end site (Veyrieras et al., 2008). This work discovered 744 genes containing at least 
one significant eQTL SNP (p<7×10-6). The single-SNP analysis, however, does not assess the 
variance in gene expression that can be explained by the interaction of multiple SNPs in 
regulatory regions of the gene.  It has been shown that the underlying mechanisms of gene 
expression are incredibly complex, involving the binding of multiple factors to DNA to facilitate 
transcription and mRNA stability (Ravasi et al., 2010).  Furthermore, polymorphisms within the 
binding sites of multiple factors may alter binding affinities to various degrees, exerting a non-
linear influence on gene expression due to synergistic effects (Boj, Petrov, & Ferrer, 2010; Du, 
Thanos, & Maniatis, 1993).  This principle has been demonstrated with multiple sclerosis where 
severity is impacted by functional effects of two alleles in close proximity in the MHC region 
(Gregersen et al., 2006).  Despite the known complexity of gene regulation, multi-SNP interaction 
analysis has been previously examined only for genes having highly heritable expression but 
lacking single SNP associations (Dixon et al., 2007b).  As a secondary analysis of eQTLs using 
lymphoblastoid lines isolated from children with asthma, the authors successfully explain some 
of the missing heritability from single SNP analysis using interactions.  From this limited 
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assessment, the authors conclude that genetic interactions may have an important role in the 
regulation of gene expression.  From these points, we hypothesize that combinations of SNPs 
within the 500 kb window of potential transcriptional influence will alter gene expression in 
humans in a non-linear fashion, here dubbed cis-epistasis. 
An analysis of gene expression phenotypes provides a unique opportunity to 
systematically assess the degree to which epistasis, or nonlinear interactions between genetic 
variants, might influence complex human traits. Linking the HapMap cell line expression data 
from (Veyrieras et al., 2008) with publicly available genotype data on the same cell lines gives us 
a dense collection of genetic variants in regions with strong biological plausibility for non-linear 
multi-SNP interaction within 11,466 quantitative expression outcomes with established main 
effects.  Here we leverage these data to investigate the nature and degree to which cis-epistasis 
affects gene expression in humans. Furthermore, if epistasis plays an important role in 
influencing gene regulation, then it logically follows that epistasis is an important part of more 
complex downstream human disease phenotypes, as these traits are often associated to SNPs that 
alter gene expression (Gamazon et al., 2010). Finally, investigators could prioritize established 
combinations of eQTL SNPs to inform a SNP-SNP interaction analysis in complex human traits to 
reduce both the computational and multiple testing burdens that plague epistasis analysis in 
high-throughput genetic analysis. This would also motivate reanalysis of existing datasets for 
multi-SNP interactions that influence complex disease, many of which are publicly available at 
the database of genotypes and phenotypes (dbGaP) (Mailman et al., 2007). Put simply, if a study 
design that considers cis-epistasis can explain more heritability in gene expression, then genetic 
studies that account for cis-epistasis should be more fruitful. 
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Methods 
Genotype and Gene Expression Data 
As a starting point for these analyses, we retrieved the full eQTL results database and 
normalized gene expression data from the Veryrieras et al. analysis (available: 
http://eqtnminer.sourceforge.net/), containing 11,966,533 results (significant and non-
significant) from 2,437,821 distinct SNPs and 11,466 distinct microarray probes (Veyrieras et al., 
2008).  We limited all of our analyses of the raw data to these SNPs and microarray probes.  We 
analyzed SNP data from release #23 of the International HapMap project for 210 unrelated 
individuals, including 60 Yoruba (YRI) and 60 CEPH (CEU) parents, and 90 unrelated Chinese 
(CHB) and Japanese (JPT) samples (International hapmap consortium, 2007).  We retrieved gene 
expression data that was normalized first by quantile normalization within replicates and then 
median normalized across all HapMap individuals.  We then applied the normalization 
procedure from (Veyrieras et al., 2008), which is a Gaussian quantile normalization for each gene 
within each subpopulation separately to avoid results confounded by population stratification 
(the distribution of expression values within each subpopulation is now identical). 
 
Statistical Analysis 
From the single SNP results database, we extracted all SNPs with eQTL p-values <0.05 
for each microarray probe – that is, all nominally significant SNPs falling within 500KB upstream 
of the transcription start site and 500KB downstream of the transcription end site.  For each 
microarray probe, we generated all possible pair-wise combinations of SNPs, constructing 
12,107,627 two-SNP models. For each model, we performed a multiple linear regression analysis 
fitting a model with main effect terms for the two individual SNPs and a multiplicative 
interaction term. We tested for significance of interaction via a student's T-test of the interaction 
term coefficient.  All regression analyses were conducted using the 'rms' package for the R 
statistical computing environment (R Development Core Team, 2005).  Statistical significance was 
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determined by controlling the false discovery rate (FDR) at 0.20, using the 'qvalue' package 
available for R (Storey, Taylor, & Siegmund, 2004).  Linkage disequilibrium was computed using 
PLINK software, analyzing the combined set of 210 HapMap samples without phasing using the 
'--r2' option (Purcell et al., 2007). 
 
Annotation of Results Using GWAS Catalog 
The National Human Genome Research Institute (NHGRI) actively maintains a catalog of 
all significant (p<10-5) findings from published Genome-Wide Association Studies (GWAS) 
(Hindorff et al., 2009)(accessed March, 2010). The National Heart, Lung, and Blood Institute 
(NHLBI) also recently released comprehensive open access database of 118 GWAS studies 
containing 56,411 significant SNP-phenotype associations (Johnson et al., 2009). Illumina 
expression probe IDs were matched to transcripts within the Ensembl database (Release 49).  
Transcripts were matched to Ensembl Genes which have associated gene symbols within the 
Ensembl database.  These symbols were matched to the "gene" fields in the GWAS catalogs to 
assess the number of matches.  We also referenced the SNPs from our most significant results 
against these catalogs to determine if any single SNPs in the regions around our findings were 
known to influence any complex human phenotypes.  
 
Results 
 
Gene Expression in Humans is Influenced by Cis-Epistasis 
After exhaustively fitting two-SNP models between known eQTL SNPs surrounding 
each microarray probe (12,107,627 two-SNP models in total), we examined the distribution of the 
p-values from the interaction term. The full results catalog from this analysis is available online at 
http://chgr.mc.vanderbilt.edu/bushlab/. Figure 6 is a quantile-quantile plot showing that the 
distribution of interaction term p-values deviates highly from the expected uniform distribution  
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Figure 6. Quantile-quantile plot. This QQ plot shows the distribution of observed -log10(p-values) 
against the expected -log10(p-values) for the interaction term among 12,107,627 cis-epistasis models. 
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under the null hypothesis of no epistasis (diagonal line). This indicates that multi-SNP interaction 
may be common among eQTL SNPs that influence gene expression in humans. 
Because a large number of statistical tests were performed, we corrected for multiple 
testing using the false discovery rate (FDR) method described in the methods section. Of the ~12 
million two-SNP interaction models tested with multiple linear regression, 706 were still 
significant after correcting for multiple testing.  It is of note that our multiple testing correction is 
extremely conservative because our tests of interaction are not independent of each other.  The 
deviation from the null hypothesis of no interaction shown in Figure 6 suggests that there may be 
many more than 706 SNP-SNP interactions truly influencing gene expression that we are 
insufficiently powered to detect when applying our FDR correction.  These 706 significant SNP-
SNP interaction models influenced the expression of 79 unique probes, representative of 79 
unique genes. All 706 interactions mapped to one of these 79 distinct genes. The reduction from 
706 SNP-SNP interactions to 79 genes is due to correlation between statistical models, resulting 
from linkage disequilibrium (LD) between SNP 1 of model 1 and SNP 2 of model 2.  However, 
there was relatively weak LD between the two SNPs participating in each interaction; i.e. SNP 1 
and SNP 2 of model 1.  The distribution of LD statistics (measured by r²) between the SNPs in 
each interacting pair is shown in Figure 7.  The median r² was 0.043, with a median distance 
between each pair of 108KB. Taken together, this suggests that the majority of the most 
significant results are indeed epistatic effects between independent SNPs, not simple haplotype 
effects. If SNPs participating in an interaction were in tight linkage disequilibrium it would be 
difficult to distinguish between a true multi-SNP interaction and a haplotype effect that is largely 
driven by the effect of a single SNP. 
We then examined the most significant two-SNP models from each of these 79 genes, 
referencing each regulated gene to the GWAS results catalog described in the methods section.  
The GWAS results catalog contains SNPs that have been previously associated to a human 
phenotype, and the associated gene reported by the original GWAS publication.  We matched the  
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Figure 7. Linkage disequilibrium between cis-epistasis models. This shows the kernel density 
distribution of linkage disequilibrium values (r²) between the most significant interacting SNP pair 
influencing expression of 79 genes after correcting for multiple testing. 
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significant cis-epistatic interactions to the GWAS results catalog in two ways: matching the 79 
genes being regulated to the gene reported in the GWAS study, and matching SNPs participating 
in the 706 interactions to a SNP associated in a GWAS study. When matching by gene, we found 
that 20 of the 79 genes regulated by cis-epistasis have been previously reported in studies of 
approximately 20 human disease and morphological phenotypes (Table 3a).  When matching by 
SNP, we found 10 additional cis-interactions where one of the specific SNPs has been associated 
to one or more disease or morphological phenotypes in humans (Table 3b).  
For the majority the genes in Table 3, examining single SNP effects on expression only 
resulted in a nominal level of statistical significance (Table 3, columns "eQTL[1/2] P-value"). 
Examining the cis-epistasis interaction between the two SNPs allowed us to achieve a much 
greater degree of statistical significance (Table 3, columns "INT P-value" and "Model P-value").  
Furthermore, accounting for cis-epistasis allows us to explain a much larger proportion (on 
average, 15 times more) of the heritability (variance) in gene expression (Table 3, column "R²diff", 
which is the difference in variance explained by the full model accounting for the interaction, 
"R²full", and the reduced model with main effects only, "R²redu").   
 
Structural Characterization of Significant Two-SNP Interactions: Genomic Structure 
Next we examined the genomic structural characteristics of the most significant two-SNP 
epistatic interactions that impact the expression of these 79 genes.  Specifically, we examined the 
location of the two eQTL SNPs relative to each other and relative to the transcription start site 
(TSS) and transcription end site (TES) of the regulated gene. Based on structural characteristics, 
we defined four distinct classes of regulatory epistatic interactions:  upstream, where both eQTL 
SNPs lie upstream of the TSS of the gene; downstream, where both eQTL SNPs lie downstream of 
the TES; spanning, where one eQTL SNP is upstream of the TSS and one eQTL SNP is 
downstream of the TES; and intragenic, where at least one eQTL SNP lies within the genic region, 
and the other may be either upstream, downstream, or also in the genic region. 
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Table 3a. Cis-epistasis models. Significant two-SNP interactions where the regulated gene has been previously associated to one or more complex human 
disease or morphological phenotypes. The specific SNPs which interact to regulate the gene were not necessarily reported as associated to the phenotype. 
Assoc. 
Gene 
eQTL1 eQTL2 R²full R²redu R²diff 1 2 int 
LD 
(r²) 
eQTL1 
Pvalue 
eQTL2 
Pvalue 
INT 
Pvalue 
Model 
Pvalue 
GWAS Associated Phenotype 
ABCA13 rs17132158 rs6945363 0.104 0.017 0.087 1.18 1.19 -0.77 0.00 0.0308 0.0012 1.3E-05 4.8E-05 
Height,Triglycerides, 
Systolic Blood Pressure, Fasting glucose 
AEBP2 rs7135885 rs11044945 0.100 0.013 0.087 -1.36 -0.80 0.58 0.74 0.0254 0.0222 1.4E-05 7.4E-05 Insulinogenic index 
BLK rs11986748 rs2572430 0.095 0.012 0.082 1.23 0.83 -0.77 0.02 0.0346 0.0461 2.4E-05 0.00013 Lupus*, Rheumatoid arthritis* 
C10orf97 rs2883029 rs4748176 0.086 0.001 0.085 0.51 0.39 -0.47 0.02 0.0205 0.0188 1.9E-05 0.00032 Crohn's disease 
CDKL1 rs1955926 rs7151406 0.115 0.037 0.078 -0.09 1.52 -0.58 0.56 1E-06 7E-09 3.3E-05 1.4E-05 Cognitive Performance 
CPNE8 rs2387836 rs12818797 0.087 0.006 0.081 -1.19 -1.65 0.67 0.39 0.0114 0.0235 3.2E-05 0.00032 Waist circumference 
DTNB rs1369704 rs7607198 0.101 0.015 0.085 -0.02 2.94 -1.21 0.13 7E-15 0.0249 1.7E-05 7.2E-05 Type II Diabetes (T2D) 
EEFSEC rs2811484 rs2713590 0.099 0.013 0.086 -0.58 -0.28 1.24 0.00 0.0245 0.0307 1.4E-05 8E-05 Alzheimer's disease (AD) 
FRMD3 rs10868025 rs11792634 0.124 0.042 0.082 -2.03 -1.30 0.70 0.06 0.0165 0.0307 2E-05 5.5E-06 HDL cholesterol 
GNG2 rs1272117 rs3742536 0.087 0.005 0.082 -1.09 -1.23 0.90 0.01 0.0064 0.0171 2.6E-05 0.00031 AD, T2D, Crohn's disease 
GRIP2 rs2607765 rs2607737 0.093 0.009 0.084 -0.19 -0.84 0.78 0.18 0.0262 0.0355 2E-05 0.00016 Cognitive performance 
KIF7 rs17807856 rs3803530 0.081 0.003 0.078 -1.01 -0.88 0.58 0.01 0.0103 0.0012 4.4E-05 0.00057 LDL Cholesterol 
MCOLN2 rs657309 rs6690583 0.095 0.003 0.092 0.42 1.02 -0.54 0.04 3E-13 0.0223 8E-06 0.00012 Fasting glucose 
NMNAT3 rs10935317 rs7648532 0.121 0.033 0.088 1.54 1.40 -0.64 0.08 0.0273 2E-24 9.7E-06 7.1E-06 BMI, Fasting glucose 
NPY rs198723 rs16189 0.085 0.006 0.080 -0.63 -0.80 0.61 0.01 0.0461 0.0006 3.4E-05 0.00036 Early onset extreme obesity 
NRN1 rs3763180 rs7763755 0.114 0.034 0.079 -1.10 -1.05 0.59 0.00 0.0169 0.0012 2.7E-05 1.6E-05 Waist/height ratio squared 
OBFC1 rs2986059 rs3124 0.123 0.036 0.088 1.17 0.81 -0.70 0.01 0.002 0.0372 9.8E-06 5.5E-06 
Parkinson's disease,brachial artery flow 
velocity, Height,Endothelial traits 
PCM1 rs385139 rs7816561 0.101 0.019 0.082 0.76 1.17 -0.52 0.61 0.0377 0.0462 2.3E-05 6.9E-05 Triglyceride/HDL ratio 
TYK2 rs10403787 rs4804480 0.166 0.095 0.071 1.48 0.43 -0.64 0.07 0.0004 0.0006 4.1E-05 3.7E-08 Type 1 Diabetes*,Lupus 
ZBTB38 rs6802753 rs7626871 0.084 0.002 0.082 0.97 1.52 -0.76 0.08 0.0053 7E-10 2.8E-05 0.00042 Height* 
* indicates significant association of a gene to a complex human phenotype with p < 5E-8 (genome-wide significance) 
Table 3b Cis-epistasis models. Significant two-SNP interactions where one of the SNPs regulating a gene was previously associated to one or more human 
disease or morphological phenotypes. The involvement of the regulated gene in disease pathogenesis has not been investigated. 
Gene eQTL1 eQTL2 R²full R²redu R²diff 1 2 int 
LD 
(r²) 
eQTL1 
Pvalue 
eQTL2 
Pvalue 
INT 
Pvalue 
Model 
Pvalue 
GWAS Associated Phenotype 
SLIC1 rs2160683 rs9635531 0.087 0.009 0.079 1.17 1.17 -0.66 0.61 0.0461 0.0433 3.7E-05 0.00029 Crohn's disease 
TMBIM1 rs7605980 rs12471773 0.087 0.011 0.076 0.37 0.64 -0.73 0.09 0.0002 0.0408 5E-05 0.00032 Type I Diabetes 
PCM1 rs396462 rs2955427 0.091 0.003 0.088 0.95 0.92 -0.50 0.47 0.0326 0.0039 1.3E-05 0.00019 Crohn's disease 
OTUB2 rs6575354 rs12433627 0.079 0.000 0.079 -1.00 -0.90 0.58 0.00 0.0346 0.0203 4E-05 0.00071 Type I Diabetes 
DDX19A rs929840 rs2303791 0.092 0.009 0.082 1.45 0.41 -0.80 0.32 0.042 0.0135 2.4E-05 0.00019 Alzheimer's disease 
DDX19A rs929840 rs4985534 0.087 0.008 0.079 1.43 0.39 -0.79 0.33 0.042 0.0104 3.7E-05 0.00032 Alzheimer's disease 
ORMDL1 rs7568054 rs7568449 0.123 0.044 0.079 -0.24 -0.44 0.49 0.01 0.0263 3E-22 2.6E-05 5.5E-06 Amyotrophic Lateral Sclerosis 
C3orf31 rs7615782 rs440746 0.115 0.020 0.095 1.56 0.16 -0.82 0.11 0.0031 4E-17 4.9E-06 1.4E-05 Waist circumference, Hypertension 
XKR9 rs268625 rs7828552 0.137 0.051 0.085 -1.84 -1.29 0.66 0.23 0.0009 0.0002 1.1E-05 1.2E-06 Systolic blood pressure post-exercise 
C17orf53 rs228769 rs2526021 0.086 0.007 0.079 0.95 1.02 -0.58 0.61 0.0103 0.0001 3.7E-05 0.00035 Bone mineral density 
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We observed 25 upstream interactions (32%), 18 downstream interactions (23%), 17 
spanning interactions (21%), and 19 intragenic interactions (24%).  Interestingly, all our 
significant results were evenly distributed among the four structural classes, as a z-test for 
population proportions revealed no significant difference from 25%. Figure 8 shows that the four 
structural classes are distributed evenly among these most significant 79 cis-epistatic interactions. 
Figure 8 also reveals that the distribution of structural class does not correlate with gene size, 
organized vertically along the figure. 
 
Structural Characterization of Significant Two-SNP Interactions: Structure of the statistical model 
Statistical epistasis is classically defined as the deviation from additivity in a linear model 
(Fisher, 1918). We have shown that there are significant nonadditive effects impacting gene 
expression throughout the genome. Next we examined the structure of the statistical models of 
the most significant interactions impacting the 79 unique genes discussed above. Specifically, we 
examined the direction of the coefficients of both main effect terms and the interaction term in 
each statistical model. 
We found that of these 79 significant cis-epistasis interactions, the main effect coefficients 
in 75 of these models were in the same direction. That is, if inheriting one copy of the minor allele 
of a single variant caused an increase in expression, the main effect of the other SNP also resulted 
in an increase in expression. Recall that we only tested for SNP-SNP interactions among eQTL 
SNPs that had an established main effect. Interestingly, of these 75 cis-epistasis models where 
both main effects were in the same direction, the statistically significant interaction term 
coefficient was in the opposite direction. That is, if the main effect of each variant alone caused an 
increase in expression by x units, inheriting both variants resulted in an increase in expression that 
deviates significantly from the expected 2x increase.  Of the remaining four significant cis-
epistasis interactions, the main effects were in opposing directions.  For three of these four, the 
main effect coefficient of one SNP in the model approached zero after accounting for the  
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Figure 8. Genomic structure of significant cis-epistasis models.  Transcribed regions of these 79 genes 
(gray boxes) are aligned by transcription start site, ordered by gene size. Epistatically interacting SNPs that 
influence the gene's expression are shown as connected hash marks, color coded by class: upstream (blue), 
downstream (green), spanning (gray) and intragenic (red). Analysis of the genomic structure of cis-epistatic 
interactions reveals that all four structural classes are evenly represented among the most significant cis-
epistatic interactions, and that structural class does not correlate with gene size. 
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interaction.  This suggests a classical modifier effect, where one variant only exerts an effect in the 
presence of another.  In all three of these models, the presence of the “modifier SNP” (β ≈ 0) 
results in a mitigation of the main effect of the other SNP.   
The pattern of coefficients can be seen by examining ß1, ß2, and ßint for the models 
presented in Table 3 (showing only models related to a human phenotype from a GWAS). These 
results indicate that the overwhelming majority of significant non-additive two-SNP interactions 
influencing gene expression represent epistatic genetic heterogeneity rather than multiplicative 
effects. We consider this in greater detail in the discussion section below.  
We also investigated the possibility that aspects of the genomic structure of the model 
might impact the statistical nature of the interaction.  However these analyses revealed no 
significant relationships between genomic structure characteristics (such as class or the physical 
distance between the two SNPs) to the variance explained (R2) or magnitude of the interaction 
coefficient. 
 
Conclusions 
 
In this work we examined eQTL SNPs known to impact gene expression in humans for 
non-additive epistatic effects by combining transcriptome-wide expression data from HapMap 
lymphoblastoid cell lines with genome-wide SNP data from the same cell lines. Specifically, we 
analyzed over 12 million potential two-SNP interactions for cis-epistasis among SNPs known to 
regulate transcription of a nearby gene, and found that multiple independent eQTL SNPs may 
often interact to influence gene expression non-additively. After correcting for multiple testing, 
we found 706 highly significant cis-epistasis interactions that influence the expression of 79 
unique genes. 
We characterized the genomic and statistical structure of the most significant cis-epistasis 
model corresponding to each of these 79 genes. Here we discovered that in the vast majority of 
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cis-epistasis interactions (1) the main effects are in the same direction, and (2) the interaction was 
in the opposite direction. While still considered a nonlinear epistatic interaction, the structure of 
this type of model is referred to as a heterogeneity model (Cordell, 2002; Neuman & Rice, 1992) 
rather than a multiplicative model. Genetic heterogeneity is a serious concern with large-scale 
genetic studies, and is often cited as a reason for the widespread lack of replication in GWAS 
studies (McClellan et al., 2010; Sillanpaa & Auranen, 2004). Because epistatic genetic 
heterogeneity may commonly impact regulation of gene expression, and since SNPs associated 
with complex human phenotypes often result in changes of gene expression (Gamazon et al., 
2010), it follows that cis-epistatic genetic heterogeneity could exert a significant influence over 
complex human traits and should be investigated as such.  Others have recently argued that 
epistatic genetic heterogeneity should be considered when analyzing genomic data for 
association to disease (Moore, Asselbergs, & Williams, 2010b). Despite the fact that statistical 
tools have been available for some time now to accomplish this (Lunetta, Hayward, Segal, & Van, 
2004; Thornton-Wells et al., 2004), analyses of genome-wide datasets accounting for the 
possibility of cis-epistasis is a task rarely undertaken.  Accounting for genetic heterogeneity in 
gene expression may improve the replicability of existing genetic association studies.   
By matching cis-epistasis interactions to the GWAS results catalogs by SNP, we 
discovered that of the 79 significant cis-epistasis interactions, 10 contained one SNP previously 
associated to a human phenotype via GWAS studies. Nearly all of these associations initially fell 
short of “genome-wide” statistical significance (Pe'er, Yelensky, Altshuler, & Daly, 2008) and thus 
would not be reported in the literature as a relevant gene for the phenotype.  Furthermore, the 
statistical significance of each single SNP on the expression of a gene is weak.  However, when 
we consider the joint effect of both SNPs involved in the cis-epistasis interaction, we see a 
dramatic improvement in the variance of gene expression explained.  As such, we hypothesize 
that some of these reported associations from the GWAS catalog would show stronger 
associations to the phenotype if modeled with their cis-epistasis partner SNP.  In light of the 
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prevalence of cis-epistatic interactions, these examples provide motivation to re-examine existing 
datasets for cis-epistatic effects on human phenotypes.  Our models provide a compelling set of 
specific regulatory hypotheses to examine in existing data.   
Many new approaches have been recently used to examine epistasis in GWAS data 
(Baranzini et al., 2009; Bush et al., 2009; Peng et al., 2010; Ruano et al., 2010).  All of these 
approaches focus on interactions among SNPs within genes related to a common biological 
mechanism, such as pathways, and structural or functional similarity.  With these approaches, 
interaction models consist of SNPs from each of two distant genes – a trans-epistasis effect.  In 
most cases, this precludes the possibility of capturing cis-epstasis effects.  While trans-epistasis 
effects are likely to be important for complex disease etiology, we argue that cis-epistasis may be 
of equal or greater importance, and coupling cis- and trans-epistasis analysis methods may be 
more successful.   
Furthermore, the available tools for the analysis of multi-locus interactions in genetic 
association studies (including the ATHENA platform discussed in Chapter II) are not likely to 
discover the cis-epstasis effects we describe here.  Knowledge-based approaches generally test 
models of trans-epistasis (as discussed above).  Sliding window-based haplotype association 
approaches typically use window sizes based on a fixed physical distance or number of SNPs 
(Lin, Chakravarti, & Cutler, 2004).  These approaches would likely not discover cis-epstasis 
effects due to the variable and often large distances between the pairs of regulatory SNPs within 
the model (see Figure 8). 
Additionally, any gene-based analysis approach that uses SNP data requires mapping 
SNPs to genes.  This is exclusively done using either physical distance (base-pair proximity) or 
genetic distance (linkage disequilibrium).  The genomic window generated using these 
approaches is typically conservative, including a small region upstream and downstream of the 
gene region.  Others have shown in model organisms that regulatory elements exert effects from 
extremely long distances (Chandler, Chandler, McFarland, & Mortlock, 2007).  Likewise, many of 
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the single SNP eQTLs used in the examination of this study illustrate long range regulatory 
effects (Veyrieras et al., 2008).  From our analysis, we provide additional evidence that SNPs can 
influence the regulation of a gene at great distances from the transcription start site, and existing 
SNP-to-gene mapping approaches should take this into account.   
We therefore suggest that the re-analysis of existing datasets and the development of 
new analysis approaches take into account the possibility that long range regulatory interactions 
could alter gene expression and thus influence human phenotypes.  By accounting for more 
variance in gene expression (thus increasing statistical power), this will improve performance of 
analytical methods and potentially improve the replicability of new GWAS findings.  One basic 
approach would be to use the models we have generated as templates for the analysis of cis-
epistasis in existing and future personal genomics studies.  The 79 genes we identified after 
multiple testing correction suggest the most compelling cases of cis-epistasis.  However, 
interaction models with less significant p-values may explain sufficient variance in a gene’s 
expression to resolve an association with a phenotype. 
One limitation of this study is that whole-transcriptome data was available for only 210 
HapMap samples.  However, dense genome-wide SNP data is available for 1397 individuals in 11 
diverse human sub-populations through the HapMap project (International hapmap consortium, 
2007), so if additional gene expression data were collected we could improve the statistical power 
of this analysis to detect cis-epistasis effects.  Also, we only considered interactions among eQTL 
SNPs with a nominally significant regulatory effect (p < 0.05).  A reanalysis of these data 
including all SNPs, (even those without a known regulatory effect) would be straightforward, 
perhaps revealing additional cis-epistasis effects; however this would cause a power loss from the 
increased burden of multiple testing correction.    
In summary, we have shown that cis-epistasis is an important phenomenon regulating 
gene expression in humans.  Using this information, we suggest ways in which the performance 
of existing and future analysis approaches can be improved, and how additional insights into 
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human biology and disease pathogenesis could be gained from personal genomics studies.  
Likewise, future research and development on incorporating domain knowledge into the 
ATHENA algorithm introduced in Chapter II should consider cis-epistasis as a source of domain 
knowledge, rather than only considering potential trans-epistatic SNP-SNP interaction models 
from distant genes. 
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CHAPTER IV 
 
QUALITY CONTROL PROCEDURES FOR  
GENOME WIDE ASSOCIATION STUDIES4 
 
 
Introduction 
 
As discussed in previous chapters, genome-wide association studies (GWAS) are 
commonly used to identify common single nucleotide polymorphisms (SNPs) that influence 
human traits. GWAS have been conducted at increasing frequency using case-control, 
population-based prospective, and cross-sectional study designs (Klein et al., 2005; Frayling, 
2007; Newton-Cheh et al., 2009; Kathiresan et al., 2009; Willer et al., 2008b; Hindorff et al., 2009).  
More recently, GWAS are being conducted in cohorts that are clinic-based (Barber et al., 2010; 
Daly et al., 2009; Link et al., 2008; Thompson et al., 2009). As a result, GWAS may soon move the 
field of genomics into clinical practice. 
Whether the goal is to identify predictors of outcomes or to discover new biology 
underlying a trait of interest, the capability of GWAS to identify true genetic associations 
depends upon the overall quality of the data. Even simple statistical tests of association are 
compromised in the context of genome-wide SNP data that have not been properly cleaned, 
potentially leading to false-negatives and false-positive associations (Pluzhnikov et al., 2010). 
Additionally, problems with the overall data quality will likely affect downstream analyses and 
studies beyond the initial GWAS.  For example, the National Human Genome Research Institute 
(NHGRI) actively maintains an online catalog of GWAS results and associated publications 
(Hindorff et al., 2009), which stimulates downstream studies of replication and characterization 
in independent populations.  Compromised data quality in the discovery phase may lead to false 
                                                     
4
 Adapted in part from: Turner S.D., Armstrong L., Bradford Y., Carlson C., Crawford D.C., Crenshaw 
A.T., de Andrede M., Doheny K., Haines J.L., Hayes G., Jarvik G., Jiang L., Ling H., Kullo I., Li R., 
Manolio T.A., Matsumoto M., McCarty C.A., McDavid A., Mirel D., Paschall J., Pugh E., Rasmussen 
L.V., Wilke R.A., Zuvich R.L., Ritchie M.D. (2011).  "Quality Control procedures for Genome-Wide 
Association Studies." Current Protocols in Human Genetics. In press. 
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positives that are carried forward into replication studies at great cost both in time and expense. 
Also, the National Institutes of Health (NIH) now mandates that secure, encrypted copies of 
primary GWAS data funded by NIH be made publicly available (with controlled access) for 
secondary analyses. These accessible datasets are maintained by the National Center for 
Biotechnology Information (NCBI) in the database of Genotypes and Phenotypes (dbGaP).  
dbGaP provides both open and controlled access, which allow for both broad release of non-
sensitive information, and restricted access to datasets involving genomic data and phenotypic 
information, respectively (Mailman et al., 2007).  Data access through dbGaP is commonly used 
for replication and meta-analysis, both of which will be compromised by poor quality data.  
Genotyping technology and allele calling algorithms continue to improve and quality-
improvement strategies continue to ensure that only reliable, rigorously scrutinized markers and 
samples are used for analysis. Reconciling genetic data with clinical and self-reported data (e.g., 
sex or familial relationships) can potentially identify sample identity problems caused by sample 
handling mishaps. Batch effects, population stratification, and sample relatedness can confound 
genetic association analyses and can lead to excessive type I and type II errors. Here I discuss 
methods that can be used to detect and account for various data quality issues to better ensure 
the integrity of the primary GWAS as well as its downstream applications. 
The eMERGE (electronic MEdical Records and GEnomics) Network is an NHGRI-
supported consortium of five institutions charged with exploring the utility of DNA repositories 
coupled to Electronic Medical Record (EMR) systems for advancing discovery in genome science 
(McCarty et al., 2010a).  eMERGE also includes a special emphasis on the ethical, legal and social 
issues related to these endeavors. The five sites in eMERGE include Marshfield Clinic, Group 
Health Seattle, Vanderbilt University, Mayo Clinic, and Northwestern University.  Using an 
algorithm for a specific phenotype, each of the participating sites extracted study samples for a 
specific disease or phenotype from their EMR.  Genome-wide genotyping has been performed on 
~17,000 samples across the eMERGE network at the Broad Institute and at the Center for 
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Inherited Disease Research (CIDR) using the Illumina 660W-Quad or 1M-Duo Beadchips.  Each 
study site is conducting a GWAS, in addition to a number of cross-network analyses. These 
studies adhere to NIH’s data sharing policies, and all data generated in this study will be 
available on dbGaP (Mailman et al., 2007).  Due to the complexity involved in a single site GWAS, 
in addition to the combining of data and results across study sites, it became clear that a unified 
QC pipeline was imperative.  To facilitate this process, the eMERGE Coordinating Center at 
Vanderbilt University is leading the genomics group in the development of the eMERGE QC 
pipeline.   
Others have discussed quality control procedures for genotypic data (Laurie et al., 2010; 
Miyagawa et al., 2008; Chanock et al., 2007b; Broman, 1999). This chapter documents the QC 
procedures that I used prior to analyzing the GWAS data presented in Chapter V using the 
Marshfield Personalized Medicine Research Project and Vanderbilt BioVU cohorts. This chapter 
may also serve to instruct future investigators in QC procedures that should be implemented 
prior to analyzing GWAS data. The procedures discussed here were developed by the genomics 
group of the eMERGE network, where phenotyping and other sample information is obtained 
through sophisticated mining of the EMR. This protocol can be applied to many GWAS studies, 
regardless of phenotyping strategy. Given that most of the genotyping data available for GWAS 
is currently SNP-based, I will limit our discussion to these biallelic markers and QC procedures 
for CNV analysis will not be discussed here. 
Figure 9 shows a flowchart overview of the entire QC process, where each step is 
discussed in detail in the following sections. 
 
GWAS Data Format 
 
Regardless of the underlying study design (such as family-based or population-based), 
the most commonly used format for genetic data is the linkage, or pedigree file format (pedfile).  
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Figure 9. A flowchart overview of the entire GWAS QC process. Each topic is discussed in detail in the 
corresponding section in the text. Squares represent steps, ovals represent input or output data, and 
trapezoids represent filtering of data. 
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This file contains one individual per row, where the first six columns are identifying information 
(family ID, individual ID, father ID, mother ID, sex, phenotype), and the remaining columns are 
genotypes (2 columns per genotype; one for each allele). The genotype column-pairs correspond 
to an ordered set of SNP markers present in an associated file (.map or .bim). Additional 
phenotypes can also be stored in separate files consisting of family ID, individual ID, then extra 
columns representing additional phenotypes. There are several variations on pedfile format, 
including transposed (long) formats (tped), and compressed (binary) formats. Descriptions of 
these file formats can be found on the PLINK homepage (Table 4). PLINK is a freely available, 
open source, cross platform application for QC and analysis of GWAS data (Purcell et al., 2007). 
We used PLINK for implementing most of the eMERGE network’s QC pipeline. 
An important issue when creating a pedfile for QC analysis is the choice of strand 
orientation to use for allele calls (i.e. forward or reverse complement). While forward strand is a 
commonly used allele coding scheme, Illumina has developed a consistent and simple method to 
ensure uniformity in genotype call reporting that uses the polymorphism itself and the 
contextual surrounding sequence (“TOP/BOT” strand and “A/B” allele coding) (2009e). Since 
2005, the database of genetic variation (dbSNP) (Sherry et al., 2001) has used this designation for 
all SNP entries. We used forward strand orientation for eMERGE. Choice of strand orientation 
might depend on the strand orientation of other data used in a combined analysis or of a 
reference set used for imputation. The goal is to ensure uniformity in genotype call reporting that 
is critically important in downstream analyses, reporting, and annotation. 
 
Sample quality 
 
Sex inconsistencies and chromosomal anomalies 
One of the first procedures that should be implemented in any GWAS QC protocol is 
checking for potential sample identity problems that typically result from sample handling  
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Table 4. Software for data analysis. Useful software packages for data management, quality control, and 
statistical analysis in genome-wide association studies. 
Software 
package 
URL Purpose 
PLINK http://pngu.mgh.harvard.edu/~purcell/plink/ Free, open-source GWAS analysis software 
package. Contains many tools for data 
management, quality control, and statistical 
analysis. (PC, Mac, Linux). 
PLATO https://chgr.mc.vanderbilt.edu/plato PLatform for the Analysis, Translation, and 
Organization of large-scale data – software 
for GWAS analysis similar to PLINK. 
R http://www.r-project.org/ Free, open-source statistical computing 
software with excellent graphical capabilities. 
(PC, Mac, Linux). 
Eigensoft http://genepath.med.harvard.edu/~reich/Software.htm Free, open-source software for performing 
principal components analysis based method 
for detecting and correcting for population 
stratification in GWAS. (Linux only). 
Structure http://pritch.bsd.uchicago.edu/structure.html Free, open-source software for inferring the 
presence of distinct populations and 
assigning individuals to those populations for 
a stratified analysis. (Windows, Mac, Linux) 
MySQL 
Workbench 
http://wb.mysql.com/ Free, open-source software for creating, 
administering and querying relational 
databases. This is helpful for subsetting data, 
merging results, and joining QC metrics (e.g. 
HWE) to final association results. (Windows, 
Mac, Linux). 
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errors. One of the easiest ways to discover potential sample handling issues that result in mix-ups 
is by checking the reported sex of each individual against that predicted by the genetic data. The 
check-sex option in PLINK uses X chromosome heterozygosity rates to determine sex empirically, 
then reports individuals for whom the sex recorded in the pedfile does not match the predicted 
sex based on genetic data (example output and explanation shown in Table 5). If discrepancies 
are found (e.g. an individual is recorded being female but appears homozygous for every X 
chromosome marker), the EMR or any available study questionnaires should be reviewed to 
make a determination whether there was a sample handling mistake that caused a sample mix-
up. Checking X chromosome heterozygosity may also reveal sex chromosome anomalies such as 
Turner syndrome (females having karyotype XO), Kleinfelter syndrome (males having karyotype 
XXY), mosaic individuals (XX/XO, XX/XXY), or females with large stretches of loss-of-
heterozygosity on the X chromosome who are otherwise phenotypically normal.  
X chromosome heterozygosity is a fairly sensitive heuristic to detect sample swaps, but 
not very specific.  A variety of factors besides a crude sample mix-up will affect heterozygosity.  
Furthermore, if the goal is to enumerate as many samples with atypical sex karyotypes as 
possible, then X heterozygosity alone will not detect abnormalities such as triple X or XYY or 
homozygous X Kleinfelter syndrome.   Examining the intensity of probe binding on the sex 
chromosomes will better resolve these cases.  Illumina calls this intensity LogR ratio.  On 
Affymetrix systems, it is simply known as probe intensity.  These metrics, once suitably 
normalized, are roughly linear in copy number.  Because there are tens of thousands of loci on 
the X chromosome on modern platforms, it is appropriate to examine a subsample of markers, 
and then take a measure of central tendency of each sample such as the median or mean 
intensity.  The intensity plot provides a visualization of the intensity of X and Y probes (Figure 
10). It is expected that females should have low Y intensity and high X intensity (bottom right 
corner), and the males show have similar level of X and Y intensities (top left corner). We also 
observed two individuals with mislabeled sex as well several individuals with XXY.  Structural  
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Table 5. Example table showing output from --check-sex routine using PLINK. IID=individual id; 
PEDSEX=sex as recorded in pedfile (1=male, 2=female); SNPSEX=sex as predicted based on genetic data 
(1=male, 2=female, 0=unknown); F=X chromosome inbreeding (homozygosity) estimate.  
IID PEDSEX SNPSEX STATUS F Explanation 
1 1 1 OK 0.98 Male 
2 2 2 OK 0.03 Female 
3 2 1 PROBLEM 0.99 Recorded female, genetically male 
4 1 2 PROBLEM 0.02 Recorded male, genetically female 
5 2 0 PROBLEM 0.28 Likely a female with sex chromosome anomaly (e.g. 
XX/XO mosaic, loss-of-heterozygosity on X) 
6 1 0 PROBLEM 0.35 Likely a male with sex chromosome anomaly (e.g. XXY 
or XX/XY mosaic) 
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Figure 10. Visualization of X and Y probe intensities. The x-axis and y-axis represent the sum of the 
average over all probes for the normalized Cartesian intensity for allele A and the average over all probes 
for the normalized Cartesian intensity for allele B using all probes available on X chromosome and Y 
chromosome, respectively.  The XX (female, red circles) and XY (male, blue triangles) subjects are shown 
on the bottom right corner and on the top left corner, respectively. The plot reveals two mislabeled 
individuals (one male with the female cluster, and one female with the male cluster). Several XXY 
individuals are also clearly visible (upper right corner).  
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chromosomal variation can be identified using intensity only probes to calculate loss of 
heterozygosity and abnormal copy numbers using B allele frequency and Log R Ratio plots 
(Figure 11). The B allele frequency plot is the amount of B allele observed in a probe that should 
concentrate at zero for zero copy, at 0.5 for one copy and at 1 for two copies. Log R ratio is the 
ratio of a particular sample overall all samples. It is expected to concentrate at zero; sometimes an 
upward or downward bump is observed meaning amplification or deletion, respectively. These 
two plots can be obtained using Illumina BeadStudio/GenomeStudio. 
Depending on the aims of the study, often these individuals are not eliminated from the 
study due to sex chromosome anomalies alone. Even in carefully collected samples, the numbers 
of samples with discrepant self-reported sex having a normal karyotype is appreciable, and 
sample processing pipelines need to have these checks in place to detect such potential sample 
swaps. While it may be possible to go back to the EMR to reconcile chromosomal anomalies 
found using genetic data, researchers need to be aware of any ethical issues that may arise 
concerning return of results, and these issues should be considered and resolved prior to 
revisiting the EMR. 
 
Sample relatedness 
Another way to simultaneously examine both sample identity and pedigree integrity is 
by reconciling genomic data with self-reported relationships between individuals (if available). 
The Marshfield Personalized Medicine Research Project (PMRP) cohor t enrolled many 
participants who were related to other individuals in the dataset. Although this has consequences 
that impact which analytical approaches are appropriate for the downstream association study, 
having related samples in the dataset makes it possible to further investigate potential DNA 
sample mix-ups. Using dense marker data obtained in GWAS it is easy to compute pairwise 
kinship estimates between every individual in the study using the genome option in PLINK.  This 
procedure was not performed on the entire GWAS dataset – using only 100,000 markers yielded  
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Figure 11. Copy Number and allelic variation to detect anomalies on X chromosome. The top plot 
shows the B-Allele frequencies for all probes for one sample with total loss of heterozygosity (LOH) on X 
chromosome.  The bottom plot shows the copy number variation from the same sample on X chromosome.  
Both plots are helpful to detect regions of LOH and/or copy number variation such as deletion and 
amplification. Log R ratio is expected to concentrate at zero; sometimes an upward or downward bump is 
observed meaning amplification or deletion, respectively. 
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stable estimates of kinship coefficients. In addition to reporting the relationship type as reported 
using pedigree data (e.g. siblings, parent-child, unrelated), this procedure also calculated the 
proportion of loci where two individuals share zero, one, or two alleles identical by descent 
(IBD). Individuals sharing two alleles IBD at every locus are either monozygotic twins, or the pair 
is actually a single sample processed twice. Individuals sharing zero alleles IBD at every locus are 
unrelated. Individuals sharing one allele IBD at every locus are parent-child pairs. On average, 
siblings share zero, one, and two alleles IBD at 25%, 50%, and 25% of the genome, respectively. 
Using these data, the proportion of loci sharing one allele IBD (the Z1 column) by the proportion 
of loci where individuals share zero alleles IBD (column Z0) was plotted and points color coded 
by the relationship type. For clarity, this plot was restricted to points where the overall kinship 
coefficient is ≥ 0.05, as most of the individuals where kinship ≤ 0.05 will be unrelated. This 
relatedness plot for the Marshfield PMRP cohort is shown in Figure 12. Detailed information on 
producing this graphic using R (R Development Core Team, 2005) can be found online (Turner, 
2009). If it is believed that pedigree records obtained through ascertainment or through the EMR 
are accurate, then a point out of place (e.g. points colored as unrelated showing up where most of 
the parent-offspring pairs cluster) would be indicative of either nonpaternity, adoption, sample 
mix-up, or duplicate processing of a single individual. Further investigation using the EMR or 
ascertainment records can be used to attempt to identify the problem. It is also worth noting in 
studies where datasets from multiple sites are combined that it is possible that the same 
participant is present in more than one study. These two data points would appear genetically 
identical across sites. 
In addition to potentially discovering sample handling issues, visualizing sample 
relatedness as shown in Figure 12 also reveals any cryptic relatedness that may be present in the 
study sample. Figure 12 shows that many individuals in the Marshfield PMRP cohort who 
indicated that they were unrelated (black points) or distantly related (blue points) line up along 
the diagonal in this plot. These individuals represent second, third, fourth, and fifth degree  
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Figure 12. Relatedness plot for Marshfield PMRP cohort. Points in this plot show pairs of individuals 
plotted by their degree of relatedness: the proportion of loci where the pair shares one allele IBD (Z1) by 
the proportion of loci where the pair shares zero alleles IBD (Z0). These values are obtained from PLINK 
using the genome option. Pairs are color-coded by the type of relationship determined by the pedigree 
information embedded in the pedfile (also reported by PLINK).  This plot omits pairs of individuals having 
an overall kinship coefficient < 0.05 for clarity. There is a pair of monozygotic twins represented by a point 
in the lower left at (0,0), because they share two alleles IBD at every locus across the genome. 
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relatives. If treated as independent samples in the downstream analyses, having many related 
samples in the dataset would result in increased type I and type II errors, thus analytical methods 
such as mixed model regression (Aulchenko, de Koning, & Haley, 2007) must be used in place of 
simple linear or logistic regression. Figure 13 shows another way to visualize the degree of 
relatedness in the Marshfield PMRP cohort by plotting a histogram of the distribution of kinship 
coefficients over 0.05 between all pairs of individuals in the dataset.  
 
Population substructure 
Population stratification occurs when the study samples comprise multiple groups of 
individuals who differ systematically in both genetic ancestry and the phenotype under 
investigation.  Spurious apparent associations would be due to differences in ancestry rather than 
true association of alleles to disease (Cardon et al., 2003). Thus it is critical to check for population 
stratification within the study samples and leverage this information to inform the downstream 
analyses. 
One strategy for avoiding bias induced by population stratification is to ensure that 
study samples are drawn from a relatively homogenous population as discussed in Chapter I. 
One of the sites in the eMERGE network represents such a sample, as over 98% of the study 
sample self-reported “Caucasian,” on a study questionnaire. This percentage is consistent with 
data from the 2000 Census (2000), and self-report often shows very high correspondence with 
genetically inferred ancestry (Tang et al., 2005).  Some clinics, such as the Vanderbilt BioVU 
dataset discussed in Chapter V, record ethnicity via observer-report (typically a clerk or nurse’s 
aide). Even in this settings, observer-reported ancestry closely matches genetically inferred 
ancestry, especially for populations of European descent (Dumitrescu et al., 2010).  However, as 
discussed in Chapter I, population-based diverse samples are often desirable for genetic 
association studies focused on characterizing previous GWAS or candidate gene discoveries 
made in one population (Manolio, 2009). The eMERGE network is currently combining samples  
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Figure 13. Kinship coefficient distribution. This histogram shows the distribution of pairwise kinship 
coefficients (where kinship coefficient is greater than 0.05). The peak over 0.5 represents first degree 
relatives (parent-offspring, full siblings). The peak over 0.25 represents second degree relatives (half 
siblings, avuncular, grandparent-grandchild). Third and fourth degree relatives begin to blend into more 
distantly related samples between zero and 0.125. 
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from all five sites for a joint analysis, which may result in population stratification in the 
combined sample, if both allele frequencies and outcomes differ between sites. 
Statistical methodology for detecting and adjusting for population stratification in GWAS 
was covered in great detail in Chapter I.  Briefly, genomic control (Devlin et al., 1999; Reich et al., 
2001), aims to control for population stratification by first estimating an inflation factor, then 
adjusting all of the test statistics downward by this factor. Structured association (Pritchard et al., 
2000), uses genotype data to infer population structure and subsequently performs tests of 
association within each inferred subpopulation. STRUCTURE may also be used to identify 
individual samples that do not cluster with the majority of the samples.  These samples may then 
be eliminated from the analysis. Eigenstrat (Price et al., 2006; Patterson et al., 2006) uses principal 
components analysis to explicitly detect and adjust for population stratification on a genome-
wide scale in large sample sizes in a computationally efficient manner.  This method may be 
preferred over a stratified analysis because the combined sample often yields more powerful 
statistical tests, even after adjusting for significant eigenvectors (Zhang, Wang, & Deng, 2008a). 
Using Eigensoft requires dense genotyping coverage. The eMERGE genomics working group 
recommends using all the default options, including 100,000 randomly chosen high-quality 
markers. There are several SNPs in the HLA region on chromosome 6, in the lactase locus on 
chromosome 2, and in the inversion regions on 8p23 and 17q21.31 common in populations of 
European ancestry (Novembre et al., 2008) that are sources of stratification that will often appear 
in the top principal components. While one may exclude these SNPs from such an analysis, it is 
unknown if any similar inversions exist at appreciable frequency in non-European populations. 
The Eigensoft analysis will result in the computation of 10 principal components. If any of these 
eigenvectors are significantly associated with the phenotype under study, it is recommended that 
these eigenvectors be used as covariates in a multiple regression model in any downstream 
analysis to correct for any bias due to population stratification. Alternatively, if it is expected that 
only a very small number of samples represent ethnic outliers in the study population, using 
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Eigenstrat with iterative outlier removal, and reconciling these individuals with other ancestry 
information such as self-report could be used to identify a coherent set of ethnic outliers (which 
are identified statistically as outliers and self-report as outliers) to potentially exclude from the 
analysis, rather than adjusting for many eigenvectors during the analysis only to retain a very 
small number of samples. 
 
Sample genotyping efficiency / call rate 
Genotyping efficiency, or call rate, is an issue which will be discussed in greater depth in 
the Marker Quality section below.  A large proportion of SNP assays failing on an individual 
DNA sample may be indicative of a poor quality DNA sample, which could lead to aberrant 
genotype calling. Samples with low genotyping efficiency, or call rate, should be eliminated from 
further analysis. A recommended threshold is 98-99% efficiency, after first removing markers 
which have a low genotype call rate across samples. The suggested 98-99% threshold is an 
approximate threshold – the exact threshold may vary from study to study depending on the 
genotyping platform used, quality of the DNA samples used, and the variability in human and 
equipment error in genotyping. The threshold should be determined based on a goal whereby a 
balance minimizing the number of samples dropped and maximizing genotyping efficiency is 
attained. As discussed in Chapter V, we used a strict 99% call rate threshold in both the 
Marshfield PMRP and Vanderbilt BioVU cohorts described therein. Figure 14 shows the 
proportion of samples (red and blue lines) or SNPs (green line) remaining at different call rate 
thresholds using the Marshfield PMRP cohort. Genotyping efficiency can be checked using the 
missing option in PLINK. This will produce a file showing genotype missingness rate (1-
efficiency) for each individual (proportion of SNPs which failed on each sample), and for each 
SNP (proportion of individuals for which no genotype was called). Samples below a desired 
threshold can be eliminated from any downstream analyses by using the mind option in PLINK. 
Genotyping efficiency is also an important marker QC step, and is discussed below. 
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Figure 14. Proportion of SNPs or samples remaining as call rate threshold increases. The green line 
shows the propotion of SNPs remaining when SNPs are discarded if they fall below the given genotyping 
efficiency threshold. The blue line shows the proportion of samples remaining, while the red line shows the 
proportion of samples remaining if a 99% call rate threshold is applied to eliminate poor quality markers 
first. 
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Marker quality 
 
Marker genotyping efficiency / call rate 
As mentioned in the sample genotyping efficiency section above, marker genotyping 
efficiency (the proportion of samples with a genotype call for each marker) is a good indicator of 
marker quality. SNP assays that failed on a large number of samples are poor assays, and are 
likely to result in spurious calls. A recommended threshold for removing SNPs with low call rate 
is approximately 98-99%, although as mentioned in the sample genotyping efficiency section, this 
threshold may vary from study to study. Marker genotyping efficiency can be reviewed using the 
missing option in PLINK. We recommend removing poor quality SNPs before running the sample 
genotyping efficiency check discussed above, so that fewer samples will be dropped from the 
analysis simply because they were genotyped with SNP assays that had poor performance (see 
Figure 14). Markers can be removed based on call rate by using the geno option, followed by a 
threshold for a lower limit of missingness (e.g., geno 0.02 would remove SNPs with more than 2% 
missing, i.e. less than a 98% call rate). 
 
Control sample reproducibility / HapMap concordance 
It is advantageous to incorporate internal controls in the genotyping pipeline to estimate 
genotyping reproducibility rate and for selecting which markers to eliminate based on poor 
reproducibility. The eMERGE network routinely genotyped DNA samples from the HapMap cell 
lines (International hapmap consortium, 2003; International hapmap consortium, 2007). In 
addition to providing samples of known ancestry to anchor the Structure analysis discussed in 
the Population Substructure section above, genotype calls on HapMap samples can be compared to 
the corresponding reference genotypes to estimate the degree of concordance. Genotyping for the 
Marshfield PMRP and Group Health was performed by CIDR, which considered any SNP having 
more than one replicate error on HapMap samples run with the study samples to be a technical 
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failure, and only intensity data were released for these markers. CIDR also considered SNPs 
technical failures if the SNP had a call rate <85%, if the absolute difference in call rate between 
sexes is greater than 2.5%, if the absolute difference in heterozygosity between sexes is greater 
than 7%, or if cluster separation <0.20. Vanderbilt BioVU, Mayo, and Northwestern NUGene 
samples were genotyped at the Broad Institute, where technical failure was determined by call 
rate 95%, GenTrain score <0.6 (a statistical measure from Illumina’s clustering algorithm(2008a)), 
cluster separation <0.4, or more than one replicate error.   It is also advantageous to build in 
duplicate samples to estimate the reproducibility rate within study samples. By design, both 
CIDR and Broad include HapMap control samples and duplicate samples across all plates in the 
study.  It is anticipated that for accurate genotyping data, duplicate reproducibility and HapMap 
concordance of >99% are expected.  We removed any SNPs which had one or more discordant 
calls on duplicate samples. Both HapMap concordance and replicate sample concordance can be 
checked using the concordance procedure in the PLATO software (Grady et al., 2010) (Table 4) or 
by using the genome rel-check options in PLINK. By using HapMap trio samples it is also possible 
to inspect each SNP for Mendelian inconsistencies, which indicate genotyping errors if pedigree 
information is correct. Mendelian inconsistencies can be assessed using the --mendel option in 
PLINK. PLINK only detects Mendelian inconsistencies in full trios. The Mendelian-error 
procedure in PLATO will also evaluate Mendelian consistency in parent-offspring pairs or sib-
pairs with missing parental genotypes. We recommend removing or flagging any SNPs that have 
one or more Mendelian errors on HapMap control samples. While it may be possible to look for 
Mendelian inconsistencies using study samples, removal of these SNPs could potentially be 
filtering out a phenotype specific copy number variant. If this is the case, there will likely be more 
than three genotype clusters. The extra clusters or parts of them will be missing or miscalled. For 
instance, for a locus with alleles A and B, A-, AA, and AAB may all cluster together unless the 
SNP is re-called with a specific model pre-specified.   
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Minor allele frequency 
It is also important to filter SNPs based on minor allele frequency because statistical 
power is extremely low for rare SNPs. Figure 15 shows that the power to detect an association in 
a large dataset (n=10,000) with a relatively large effects (OR between 1.3 and 1.7) is extremely low 
for rare SNPs (<1% frequency). Because power to detect an association (OR=1.5, n=10,000) at a 
genome-wide significance threshold is nearly zero for a SNP with frequency 1% or less, we 
recommend removing any extremely rare SNPs (including any monomorphic SNPs, which are 
completely uninformative). The threshold chosen depends on the size of the study and the effect 
sizes expected. Power calculation software such as CaTS Power (Skol, Scott, Abecasis, & Boehnke, 
2006) or Quanto (Gauderman, 2002c) can simplify power calculations for genetic association 
studies and inform the investigator of the allele frequency below which the study becomes 
severely underpowered. Minor allele frequency can be reported for each SNP using the freq 
option in PLINK, and SNPs can be removed from the analysis using the maf option, followed by a 
lower limit threshold. SNPs with frequency too low to yield reasonable statistical power (e.g. 
below 1%) may be removed from the analysis to lighten the computational and multiple testing 
correction burden. However, in studies with very large sample sizes it may be beneficial to avoid 
removing these rare SNPs. Others have shown that nonsynonymous, possibly deleterious SNPs 
are on average rarer than synonymous SNPs that likely do not cause any adverse phenotypes 
(Gorlov, Gorlova, Sunyaev, Spitz, & Amos, 2008).  
 
Hardy-Weinberg Equilibrium 
Checking for Hardy-Weinberg Equilibrium (HWE) is one final step in the quality control 
analysis of markers in GWAS data. Under Hardy-Weinberg assumptions, allele and genotype 
frequencies can be estimated from one generation to the next. Departure from this equilibrium 
can be indicative of potential genotyping errors, population stratification, or even actual 
association to the trait under study (Wittke-Thompson, Pluzhnikov, & Cox, 2005). A very detailed  
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Figure 15. Power over minor allele frequency by odds ratio. This shows the power to detect an 
association at genome-wide significance (p<5×10-8), assuming the actual causal SNP is genotyped in a 
case-control study consisting of 5000 cases and 5000 controls of a common disease with 10% prevalence 
under an additive model at three different odds ratios. Note that when the MAF is low, power is extremely 
low even for very large effects (OR=1.7). 
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description of the key principles and assumptions of HWE and how HWE is tested and applied 
in genetic association studies is the subject of a review elsewhere (Ryckman & Williams, 2008). 
HWE can be assessed using the hardy option in PLINK.  While departure from HWE can indicate 
potential genotyping error, disequilibrium can also result from a true association. The eMERGE 
sites and others have consistently noted that many more SNPs are out of HWE at any given 
significance threshold than would be expected by chance. SNPs severely out of HWE should 
therefore not be eliminated from the analysis, but flagged for further analysis after the association 
analyses are performed. Databases such as MySQL (see Table 4) can be very useful for joining 
association statistics with HWE statistics for easy reporting. It is also beneficial to examine HWE 
in controls separately, as disease-free controls should more closely follow the assumptions that 
lead to HWE than cases, and because some true associations are expected to be out of HWE. 
SNPs that are highly associated with the trait of interest which also show highly significant 
departures from HWE, especially in controls if the outcome is discrete, should be closely 
scrutinized.  Typically HWE deviations toward an excess of heterozygotes reflect a technical 
problem in the assay, such as non-specific amplification of the target region. On many GWAS 
platforms the quantitative allelic signals at a marker, i.e. the intensity plot for the SNP,  can be 
used to screen for a technical origin of the HWE deviation: null alleles can produce multimodal 
genotype clusters in the heterozygote clusters and one of the homozygote clusters (Figure 16) or 
can produce an unexpected number of samples with no signal (Figure 17), and SNPs within 
CNVs or segmental duplications can produce clusters of genotypes intermediate between the 
three expected clusters of genotype (Figure 18) (Carlson, Smith, Stanaway, Rieder, & Nickerson, 
2006).  In the loci depicted in figures 8, 9 and 10, chi-square tests for HWE are rejected at P-values 
less than 10-80, so these represent the most egregious examples of the aforementioned behavior.  If 
no technical errors are detected then a number of biologically plausible explanations exist for 
HWE deviations toward an excess of homozygotes: population stratification, assortative mating 
and inbreeding, to name a few. 
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Figure 16. Genotype intensity plot showing multimodal genotype clusters. For each biallelic SNP, an 
Illumina assay gives raw intensity values for each of the two alleles.  Polar transformation of these 
intensities results provides normalized intensity values (Norm R on the y-axis) and allelic intensity ratios 
(Norm Theta on the x-axis). These values are used to determine SNP genotypes and copy number 
estimates.  In this example, AB and BB individuals are split into sub-clusters AB and AB', BB and BB', 
while AA cluster is unaffected.  The AB/AB' split results in some AB samples miscalled as AA (diagnosed 
by Mendelian inconsistencies in the genotypes), as well deviation from HWE due to excess homozygosity.  
Since only samples with at least one B allele demonstrate the splitting, one consistent explanation is the 
presence of a cryptic polymorphism near rs2301237 on a haplotype that contains the B allele. In this case, a 
second polymorphism (rs3114267) lies eight bases upstream from the typed polymorphism, and is in 
complete LD (D'=1, r^2=.2) with rs2301237.  
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Figure 17. Genotype intensity plot for samples with no signal. Unexpected number of clusters resulting 
in departure from HWE consistent with copy loss.  Hemizygous individuals cluster at AO and BO. 
Individuals with homozygous deletions cluster at OO and their genotype calls are missing.  The AB cluster 
remains intact, since these individuals are ipso facto diploid at the locus. Parent-parent-child Mendelian 
errors are present when at least one parent is hemizygous and produces hemizygous offspring.  The deletion 
results in excess homozygosity.  In this case, the "copy loss" appears to be a six-nucleotide insertion 
(rs71578153) coincident with rs11591064 that disrupts both A and B probes. 
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Figure 18. Genotype intensity plot showing CNVs or segmental duplications. The five observed 
clusters are most consistent with a segmental duplication, although none is curated around the locus.  A 
copy number variant would be expected to produce additional clusters above the AA and BB clusters (ie, 
AAA and BBB), as opposed to the splits being confined to strictly the heterozygous clusters.  Regardless, 
the artifact results in excess heterozygosity. 
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Batch effects 
 
Thousands of DNA samples are typically genotyped in a GWAS, which necessitates 
partitioning samples into small batches of samples processed in the lab together for genotyping 
(e.g. the set of samples on a 96 well plate). The precise size and composition of the sample batch 
depend on the array and lab process used.  Systematic differences among the composition of 
individuals in a batch (i.e. the case to control ratio or race/ethnicity of individuals on plates) and 
the within-plate accuracy and efficiency can result in batch effects – apparent associations 
confounded by batch. The problem is in essence the same problem observed with population 
stratification – namely that if there is an imbalance of cases and controls on a plate, and there are 
nonrandom (unknown) biases or inaccuracies in genotyping that differ from plate to plate – 
spurious associations will result.  
Ideally, no batch effect will be present because individuals with different phenotypes, 
sex, race, and other confounders should be plated randomly, and because modern high-
throughput genotyping technology is much more accurate, efficient, and consistent than earlier 
generations of GWAS assays. There are several approaches for examining a dataset for potential 
batch effects. One simple approach is to calculate the average minor allele frequency and average 
genotyping call rate across all SNPs for each plate. Gross differences in either of these on any 
plates can easily be identified. Another method involves coding case/control status by plate 
followed by running the GWAS analysis testing each plate against all other plates. For example, 
the status of all samples on plate or batch 1 will be coded as case, while the status of every other 
sample is to be coded control.  A GWAS analysis is to be performed (e.g. using the assoc option in 
PLINK), and both the average p-value and the number of results significant at a certain threshold 
(e.g. p<1×10-4) can be recorded. SNPs with low minor allele frequency (i.e. <5%) should be 
removed before this analysis is performed to improve the stability of test statistics.  This 
procedure should be repeated for each plate or batch in the study.  If any single plate has many 
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more or many fewer significant results, or has an average p-value that deviates from 0.5 (under 
the null the average p-value will be 0.5 over many tests), then this batch should be further 
investigated for genotyping or composition problems. If batch effects are present, methods 
similar to those used for population stratification (e.g. genomic control) may be used to mitigate 
the confounding effects.  
 
Evaluation of QC after association analysis 
 
After phenotypic association analysis, the quality control measures used should be 
evaluated. One method is to compare the observed number of statistically significant results with 
a phenotype to expectation to produce a QQ-plot as shown in Figure 6 in Chapter III. Too many 
significant results may indicate insufficient QC.  Also because no QC will catch all problematic 
SNPs, the intensity plots for statistically significant SNPs must be reviewed to make sure there 
are no obvious clustering problems.  Replication of results using different genotyping technology 
(such as TaqMan) and/or in another sample may be needed as well.  
 
Future directions 
 
The QC pipeline developed by the eMERGE network has enabled a thorough analysis of 
the quality of the genome-wide genotype data generated on the ~17,000 samples in the eMERGE 
network (this includes the samples used in the Marshfield PMRP and Vanderbilt BioVU samples 
discussed in Chapter V).  All of these data have been deposited in dbGaP along with 
corresponding quality control documents that describe all of the QC details for each dataset 
individually.  Conducting QC in parallel at the eMERGE coordinating center and study sites has 
been a tremendously valuable experience, as it led to a more thorough understanding since each 
group had to reconcile its results with others. Additionally, the genomics group is currently 
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performing a second round of QC, whereby the 17,000 subjects are being merged into one large 
dataset, and all of the previous QC steps will be performed again on the merged dataset.  It is not 
clear what novel characteristics of the genotype data will be revealed as we explore this very 
large combined dataset.  We will compare results of various QC procedures in the individual 
study sites and the merged eMERGE dataset to determine what, if anything, is learned in the 
process of merging raw data as opposed to performing a meta-analysis of the QC results. 
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 CHAPTER V 
 
KNOWLEDGE-DRIVEN MULTI-LOCUS ANALYSIS REVEALS GENE-GENE 
INTERACTIONS INFLUENCING HDL CHOLESTEROL LEVEL IN TWO 
INDEPENDENT EMR-LINKED BIOBANKS5 
 
Introduction 
 
To date, nearly 600 genome-wide association studies (GWAS) have been completed, 
investigating 150 distinct complex human traits (Hindorff et al., 2009; Manolio, 2010). Circulating 
levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-
C), and triglycerides (TG) are quantitative traits commonly measured in clinical practice and 
strongly associated with vascular disease, making them appealing traits to investigate from a 
statistical, clinical, and practical standpoint (Edmondson & Rader, 2008). The genetic factors 
underlying variability in blood lipid levels have been extensively studied using GWAS 
(Aulchenko et al., 2009; Chasman et al., 2008; Heid et al., 2008; Johansen et al., 2010; Kathiresan et 
al., 2007; Kathiresan et al., 2008; Kathiresan et al., 2009; Kooner et al., 2008; Sabatti et al., 2009; 
Sandhu et al., 2008; Saxena et al., 2007; Wallace et al., 2008; Willer et al., 2008b).  
There is particularly strong interest in the characterization of genetic factors underlying 
population variability in HDL-C (Wilke et al., 2010). In human populations, every 1 mg/dl 
decrease in HDL-C is associated with a 6% increase in cardiovascular risk (Ashen & Blumenthal, 
2005). HDL particles also appear to have direct anti-atherogenic properties in animal models 
(Rubin, Krauss, Spangler, Verstuyft, & Clift, 1991). Therefore, while these smaller particles may 
serve as a source of cholesterol esters for the larger, more atherogenic LDL particles, the HDL 
particles themselves actually appear to attenuate the development of cardiovascular disease 
(2002). HDL is under tight genetic control (h2 up to ~70% as determined by family studies) 
                                                     
5
 Adapted in part from: Turner S.D., Berg R.L., Linneman J.G., Peissig P.L., Crawford, D.C., Denny J.C., 
Roden D.M., McCarty C.A., Ritchie M.D., Wilke R.A., Knowledge-driven multi-locus analysis reveals 
gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks, PLoS 
ONE, submitted. 
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(Zhang et al., 2009), yet despite HDL’s high heritability, even some of the most well powered 
GWAS studies have only explained a very small proportion of HDL variation using common 
SNPs (Kathiresan et al., 2008; Willer et al., 2008a; Sabatti et al., 2009). This net unexplained 
variation due to genetics, often termed the “missing heritability” problem (Maher, 2008), has 
challenged GWAS studies for many complex traits beyond circulating lipid levels (Goldstein, 
2009; Manolio, 2010). 
A general explanation for this missing heritability is that it reflects forms of genetic 
variation that are not captured in the GWAS paradigm; these include rare genetic variation and 
copy number polymorphisms (Maher, 2008; Manolio, 2010), and gene-gene (GxG) and gene-
environment (GxE) interactions (Eichler et al., 2010; Manolio et al., 2009; Maher, 2008; Manolio, 
2010). GxG interaction (epistasis) is thought to be an important component of complex, 
multifactorial diseases due to the complexity of biological systems (Tyler et al., 2009). Data from 
animal models provide compelling support for the role of GxG interaction in the control of 
complex traits (Shao et al., 2008; He et al., 2010). Exploration of GxG in GWAS is often limited by 
lack of large sample sizes and statistical methods. One possible solution to the sample size 
problem is presented by the growing number of DNA repositories linked to electronic health 
records. These resources can provide cohorts of sufficient size for the characterization of GxG 
interaction.  In parallel, computational capacity and novel methodologies have emerged to make 
the search for epistasis in GWAS feasible (Cordell, 2009; Turner, Crawford, & Ritchie, 2009). 
Here we present data from a GWAS analyzing HDL-C using the Marshfield Clinic 
Personalized Medicine Research Project (PMRP) database (McCarty et al., 2010b), a node of the 
NHGRI-funded eMERGE network (electronic Medical Records and Genomics) [www.gwas.org]. 
We first conducted a genome-wide scan for SNPs associated with median HDL-C level using the 
comprehensive electronic medical records (EMRs) of 3947 PMRP participants.  We also 
constructed a modeled HDL phenotype that accounts for environmental effects such as 
population trends in age, body mass index (BMI), and relevant co-morbidities (Wilke et al., 2010). 
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We next investigated GxG interaction in this same dataset. One frequently-cited causal 
mechanism underlying GxG interaction has been variability within multiple genes in similar 
pathways, protein families, or genes with similar or redundant biological function (Aguilar et al., 
2010; Costanzo et al., 2010). We applied the Biofilter (Bush et al., 2009), a new bioinformatics 
technique that leverages domain knowledge from publicly available biological databases, to 
systematically investigate GxG interactions in this cohort. We required that any GxG interactions 
in this cohort (n = 3740 PMRP participants) showed evidence of replication in a second cohort 
from the eMERGE network (n = 1858 records from the Vanderbilt BioVU project (Ritchie et al., 
2010)).  This resulted in replicated GxG interactions associated with variation in HDL-C; all of 
which have potential biological relevance.   
 
Methods 
 
For the discovery cohort in the Marshfield PMRP, the study was approved by the 
Institutional Review Board of the Marshfield Clinic, and conducted in accordance with the basic 
principles of the Declaration of Helsinki. All study subjects in the discovery cohort provided 
informed consent allowing access to their entire electronic medical record, through their 
participation in the Marshfield Clinic Personalized Medicine Research Project (PMRP). The 
replication cohort was constructed from a de-identified mirror image of the electronic medical 
record at Vanderbilt University (BioVU). BioVU accrues DNA samples extracted from discarded 
blood samples from routine clinical care. The project has been reviewed and approved at 
multiple levels, including the Institutional Review Board, internal and external ethics committees, 
Community Advisory Board, legal department, and the Federal Office of Human Research 
Protection, and this oversight is ongoing (Roden et al., 2008). The PMRP database and BioVU are 
both eMERGE nodes, and are two of the largest practice-based biobanks in the U.S. with over 
20,000 in the PMRP and over 95,000 in BioVU as of September, 2010 (McCarty, Wilke, 
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Giampietro, Wesbrook S., & Caldwell, 2005; McCarty, Mukesh, Giampietro, & Wilke, 2007) 
(Ritchie et al., 2010). 
 
Phenotyping 
To facilitate the construction of accurate prediction models for cardiometabolic risk, the 
eMERGE network has begun extracting clinical lipid data from multiple participating sites.  The 
Marshfield Clinic in Central Wisconsin has one of the oldest internally developed EMRs in the 
US, with coded diagnoses dating back to the early 1960's and laboratory observations dating back 
to 1985.  The EMR data collected for clinical care is transferred daily into the Marshfield Clinic 
Data Warehouse where it is made available for research. We modeled lipid variables using this 
data source for the participants in the Marshfield PMRP cohort (Wilke et al., 2010).  
The PMRP demographics reflect the composition of the Central Wisconsin community, 
and the corresponding dataset has a distribution of fasting lipid levels similar to that reported by 
NHANES III (Carroll et al., 2005) for European Americans (non-Hispanic whites). At present, the 
PMRP Biobank contains data from over 20,000 adult participants; more than 10,000 individuals 
(54%) have impaired fasting glucose; >8,000 (41%) have hypertriglyceridemia; and >9,000 (48%) 
have reduced levels of HDL cholesterol according to criteria published by NCEP ATP-III (2001; 
Johnson & Weinstock, 2006). 
The eMERGE network design includes selection of ~3,000 subjects with a predesignated 
phenotype at each node for genome-wide genotyping.  In PRMP, the primary phenotype was 
cataract (n=3,947 subjects). This phenotype resulted in a set enriched for older adults (age range 
52 to 90 years, mean age 72). The set included 3,740 individuals with at least two HDL 
measurements available for use in the present analysis. Due to the longitudinal nature of these 
data (2 to 78 lipid data points per individual; mean = 14.4 ± 10.1 data points), we defined two 
phenotypes to be used in the analyses below: (1) median HDL and (2) modeled HDL as 
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previously described (Wilke et al., 2010). All HDL measurements for every individual were 
extracted from the EMR.  
For the single-locus analysis of HDL level in the Marshfield PMRP, a simple median 
HDL level was computed for every individual who had at least two or more HDL datapoints in 
the record.  Analyses using median HDL included adjustments for smoking, age, age², BMI, 
BMI², and gender, as all of these factors showed highly significant associations with median 
HDL. A second HDL measurement, termed here as modeled HDL, was also calculated for 
individuals in the Marshfield dataset. To calculate a modeled HDL for an individual, we 
extracted all lipid data and censored any HDL data acquired after lipid treatment or the onset of 
a relevant co-morbidity, and then used population-based trends in age and BMI to adjust 
individual estimates (Wilke et al., 2010). Records were censored at the first date of diagnosis for 
the following clinical co-morbidities known to influence circulating lipid levels: cancer, diabetes 
mellitus, and thyroid disease. Cancer (any malignancy except two common skin cancers - basal 
cell carcinoma and squamous cell carcinoma of the skin) was censored based on ICD-9 codes in 
the EMR. Thyroid disease and diabetes were assessed from the EMR using an electronic 
phenotyping algorithm available at the eMERGE website (www.gwas.org). Smoking status was 
acquired via information provided on a questionnaire provided at study entry, later confirmed 
by interview. Records were also censored at the first date of prescription for medications known 
to alter circulating lipid levels (either therapeutically or through an indirect interaction), 
including statins, fibric acid derivatives, niacin, and exogenous gonadal steroids. These data were 
assessed from the EMR using natural language processing (NLP) (Peissig et al., 2007; Wilke et al., 
2008; Xu et al., 2010; Chen, Hripcsak, Xu, Markatou, & Friedman, 2008). These algorithms have 
been validated and published (Peissig et al., 2007), and the programming pseudocode is freely 
available through the eMERGE network (www.gwas.org).  
For the gene-gene interaction analysis, we replicated findings using independent samples 
from BioVU, the EMR-derived DNA databank at Vanderbilt University Medical Center (Ritchie 
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et al., 2010; Denny et al., 2010b). The primary eMERGE phenotype at this site is variability in the 
duration of the QRS complex on the normal electrocardiogram.  Replication of the gene-gene 
interaction analysis in the Marshfield PMRP was conducted in 1,858 individuals from the 
Vanderbilt BioVU dataset having at least two HDL measurements extracted from a de-identified 
synthetic derivative of the EMR. Because the additional clinical data mentioned above were not 
available for samples in this dataset, no modeled HDL could be computed on these data, and no 
adjustments were made in the gene-gene interaction analysis. It is, however, unlikely that any of 
these variables will confound any association to a gene-gene interaction replicating across both 
the Marshfield PMRP and Vanderbilt BioVU samples. 
 
Genotyping and Quality Control 
Genotyping for the Marshfield PMRP samples was performed as part of the eMERGE 
network at the Center for Inherited Disease Research (CIDR) at Johns Hopkins University. The 
Illumina Human660W-Quadv1_A genotyping platform was used for this study. This platform 
consists of 560,635 SNPs and 96,731 intensity-only probes. Genotyping calls were made at CIDR 
using BeadStudio version 3.3.7. Our discovery cohort includes 3,947 samples from the Marshfield 
PMRP, 21 blind duplicates, and 85 HapMap controls. The HapMap controls include 44 CEPH, 32 
Yoruba, 5 Japanese, and 4 Han Chinese; 40 independent HapMap replicate pair experiments, 19 
independent HapMap trio experiments and 8 independent parent-child pairs were defined. The 
HapMap concordance rate was 99.8%. The blind duplicates reproducibility rate was 99.99%.  
Genotyping for the Vanderbilt BioVU samples was performed as part of eMERGE 
primarily at the Broad Institute. A small number of BioVU samples, where the primary 
phenotype of interest was dementia were genotyped at CIDR. Similar to the PMRP samples, most 
samples were genotyped for SNPs on the Illumina Human660W-Quadv1_A platform, although a 
subset of these samples were genotyped on the Illumina 1M-Duo BeadChip (those who were 
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known to be African American), which included all the SNPs on the 660W platform in addition to 
extra SNPs that were not considered in this analysis.  
Genome-wide SNP data were cleaned using the eMERGE quality control (QC) pipeline 
developed by the eMERGE Genomics Working Group (Turner et al., 2010a). This process 
includes evaluation of sample and marker call rate, gender anomalies, duplicate and HapMap 
concordance, batch effects, Hardy-Weinberg equilibrium, sample relatedness, and population 
stratification. We also removed any SNPs with a minor allele frequency less than 1%, as power to 
detect associations with these variants was low. After QC and minor allele frequency filtering, 
522,204 SNPs were used for the single locus analysis in the Marshfield PMRP dataset. Seven 
individuals were removed due to low (<99%) call rate. Reconciling ancestry using self-report, 
principle components (Price et al., 2006), and structured analysis resulted in exclsuion of a further 
37 genetic ancestry outliers.  After excluding these samples, none of the top ten principal 
components were significant (Price et al., 2006) or explained more than one tenth of one percent 
of HDL variation, and so no adjustment for principal components of ancestry was used in this 
sample. For the gene-gene interaction replication set using Vanderbilt BioVU samples, we 
identified and excluded 5 ethnic outliers and adjusted analyses for two marginally significant 
principle components using Eigensoft (Price et al., 2006). All genotype data and detailed 
documentation of the quality control procedures summarized here have been deposited and are 
available at dbGaP (Mailman et al., 2007).  
 
Statistical analysis 
More than half of the individuals in the Marshfield dataset had a first, second, or third 
degree relative also in the dataset.  To allow for the inclusion of related individuals without 
inflating the type I error rate in the single-locus analysis, we performed the GWAS analysis using 
a linear mixed effects analysis (Aulchenko et al., 2007) with GenABEL (Aulchenko, Ripke, Isaacs, 
& van Duijn, 2007) implemented in the R statistical computing environment (R Development 
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Core Team, 2005). Residuals from this model are essentially free from familial correlations, and 
can be used in a simple linear regression model for each SNP, which was performed using 
PLINK (Purcell et al., 2007).  Genome-wide statistical significance was determined using a 
Bonferroni correction. Figure 23 and Figure 24 were produced using the LocusZoom software 
(Willer et al., 2010). 
For analyses of gene-gene interaction, the Biofilter is a bioinformatics algorithm that 
leverages domain knowledge from publicly available biological databases among SNPs from 
biologically plausible gene sets sharing physiological or biochemical similarity (or that have been 
previously associated with the phenotype under investigation) (Bush et al., 2009). The rationale 
for using the Biofilter is to reduce both the computational and multiple testing burdens inherent 
in testing for gene-gene interactions. The Biofilter quantifies evidence in support of a particular 
gene-gene interaction model by counting the number of public database sources that 
independently link the two genes within a similar biological mechanism. Choosing to be 
conservative, we required that any gene-gene model be independently supported by four sources 
of biological knowledge among the following six: the Gene Ontology(Ashburner et al., 2000); the 
Database of Interacting Proteins(Xenarios et al., 2002); the Protein Families Database(Bateman et 
al., 2004; Finn et al., 2008); the Kyoto Encyclopedia of Genes and Genomes (KEGG)(Kanehisa et 
al., 2000); Reactome(Vastrik et al., 2007); or NetPath(2008b). This criterion identified 22,769 SNP-
SNP interactions that were tested for association to HDL-C levels in the Marshfield PMRP, and 
significant results were followed up using the Vanderbilt BioVU cohort. Figure 19 is a flow 
diagram illustrating an overview of the analysis plan. 
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Figure 19. Flow diagram overview of the analysis plan. For the single locus analysis in the Marshfield 
PMRP cohort, a genome-wide association study was performed for both median and modeled HDL-C (see 
Phenotyping section in Methods). For the multilocus analysis, the Biofilter was used to generate putative 
multilocus interaction models that were tested for association with median HDL-C in the Marshfield PMRP 
cohort. The Vanderbilt BioVU cohort was used for replication. See the Methods and Results sections.  
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Results 
 
Sample Summary Statistics 
Genome-wide association analyses were conducted in the Marshfield PMRP cohort using 
522,204 SNPs which passed rigorous quality control procedures established by the eMERGE 
network. This analysis was performed for  both median adjusted HDL-C and the modeled HDL-
C phenotype (censored according to medication exposure and relevant co-morbidities). Table 6 
summarizes the clinical characteristics of the Marshfield population.  There were 1,541 male 
(41%) and 2,199 female study subjects (total 3,740) with clinical laboratory records containing at 
least two fasting HDL measurements that could be used in the median HDL-C analysis. Of these 
3,740 samples, 2,190 had used statins, 883 have had hypothyroidism or hyperthyroidism, 733 
have had cancer, 1,515 reported having ever smoked, and 301 are current smokers.  
Nested within this group of 3,740 unique individuals, there were 1,142 male and 1,386 
female study subjects (total 2,528) with a clinical laboratory record complete enough to construct 
a more rigorous modeled HDL-C phenotype (censored according to medication exposure and 
relevant co-morbidities).  Although the sample size for modeled HDL-C was lower than the 
sample size for median adjusted HDL-C (because censoring left no analyzable data for some 
individuals), we performed the analyses using both phenotypes. Our reasoning was that 
modeled HDL-C  has the potential of revealing novel associations otherwise masked by the 
presence of anabolic/catabolic disorders and/or clinical intervention.   
Gender was the most reliable clinical predictor of median HDL-C level in the Marshfield 
PMRP cohort. The average HDL-C concentration (± standard deviation) was  45.9±10.9 mg/dl in 
males, and 58.5±14.3 mg/dl in females (Figure 20), p=2e-163.  This observation is consistent with 
the established literature (Johnson et al., 2006; 2002). We therefore also included gender as a 
covariate in the model for each SNP association.  We fit a linear regression model for each SNP 
assuming an additive allelic model.  To allow for related samples without inflating the type I  
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Table 6. Descriptive statistics of clinical variables in the Marshfield PMRP cohort.  
 N Median Mean SD Min Max 
Age 
(years) 
3,964 72 72.16 11.03 52 90 
Weight 
(kilograms) 
3,925 80.7 82.92 18.63 34.5 186 
Height 
(centimeters) 
3,927 165.1 166.88 9.63 121.9 195.6 
BMI 
(kg/m²) 
3,923 28.8 29.68 5.79 16.1 64.5 
Modeled HDL-C 
(mg/dl) 
2,528 49.1 50.8 13.44 19.8 114.7 
Median HDL-C 
(mg/dl) 
3,740 51 53.4 14.43 22 127.5 
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Figure 20. Distribution of HDL-C concentration. Distribution of HDL-C concentration (mg/dL) is 
shown for males (blue) and females (red) in the Marshfield PMRP dataset. 
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error rate, regression on each SNP was performed using residuals from the linear mixed effects 
model that allowed for a random polygenic effect (see methods section).   
 
Single Locus GWAS Analysis: Median Adjusted HDL-C 
Figure 21 summarizes the results from our genome-wide association study, showing the 
–log10(P-value) for each SNP from the analysis of median HDL-C level, adjusted for smoking, 
age, age², BMI, BMI², and gender. Figure 22 shows the quantile-quantile plot of the –log10(P-
values) from this analysis plotted against the expected distribution of P-values under the null 
hypothesis.  Median adjusted HDL-C level in the Marshfield PMRP cohort was very strongly 
associated with SNPs in cholesterol ester transfer protein (CETP) on chromosome 16, and 
strongly associated with hepatic lipase (LIPC) on chromosome 15. Both CETP and LIPC have 
previously been implicated in cholesterol homeostasis in other genome-wide association studies 
(Aulchenko et al., 2009; Kathiresan et al., 2008; Kathiresan et al., 2009; Sabatti et al., 2009; Willer et 
al., 2008b).  The SNP with the strongest evidence for association with median HDL-C was 
rs3764261 (p=1.22e-25), 2.5kb upstream of the CETP transcription start site.  This SNP alone 
accounted for approximately 3% of the variance in median adjusted HDL-C level. This SNP is in 
LD (r²>0.8 in HapMap CEU) with rs247616 (not genotyped here), an eQTL that contributes to cis-
regulation of CETP mRNA levels in HapMap lymphoblastoid cell lines (Veyrieras et al., 2008).  
There were several other strongly associated variants upstream of the CETP transcription start 
site, and we observed association between HDL-C and a well-characterized nonsynonymous 
coding SNP, rs5882 (p=4.1e-7), known to encode a valine to isoleucine change at amino acid 
position 422 in the CETP gene product. A previous study in Ashkenazi Jews with exceptional 
longevity has revealed  that individuals with the V/V genotype at this site demonstrate increased 
lipoprotein sizes and lower serum CETP concentration, both of which are heritable and promote 
successful aging (Barzilai et al., 2003). 
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Figure 21. Summary of genome-wide association results. This manhattan plot shows the –log10(P-
values) from linear mixed effects regression model using the natural log tranformed median HDL-C level 
in the Marshfield PMRP sample, adjusted for smoking, age, age², BMI, BMI², and gender. The red line 
indicates a Bonferroni-corrected significance threshold. Genes described in the results and the discussion 
sections are highlighted in green: ADIPOQ (chromosome 3), LPL (chromosome 8), TRIB1 (chromosome 
8), APOA1/C3/A4/A5 (chromosome 11), LIPC (chromosome 15), and CETP (chromosome 16). 
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Figure 22. Q-Q plot of P-values. Quantile-quantile plot of the –log10(P-values) from the median adjusted 
HDL-C analysis in the Marshfield PMRP cohort plotted against the expected null distribution. 
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The other signal observed at a level of genome-wide significance was in hepatic lipase 
(LIPC). Variants in this gene have also been associated with HDL-C level in several previous 
studies (Aulchenko et al., 2009; Kathiresan et al., 2008; Kathiresan et al., 2009; Sabatti et al., 2009; 
Willer et al., 2008b). The SNP in the LIPC locus with the strongest association in our study cohort 
was rs11855284 (p=3.92e-14), residing 13.5kb upstream of the LIPC transcription start site on 
chromosome 15.  The most significantly associated SNP within the LIPC genic region was intronic 
SNP rs261336 (p=5.25e-6). These two SNPs explained 1.6% and 0.5% of the variance in HDL-C 
cholesterol, respectively.  
Our most significant signal that did not meet genome-wide significance was rs12678919 
(p=1.99e-7), a SNP in an intergenic region 19kb downstream of lipoprotein lipase (LPL) on 
chromosome 8. This SNP explained 0.7% of the variance in HDL cholesterol. It is noteworthy that 
a different variant at the LPL locus (rs253) was identified in subsequent gene-gene interaction 
analyses here. Details are discussed further below. 
 
Single Locus GWAS Analysis: Modeled HDL-C 
Our data were derived from an electronic medical record. Therefore, we also tested each 
SNP for genome-wide association with modeled HDL-C as the outcome, a trait which censors by 
onset of relevant co-morbidities or usage of lipid-modifying drugs and adjusts for population 
trends in age and BMI (Wilke et al., 2010).  Because this more rigorous phenotype required data 
for several covariates, complete data was only available on 2,528 samples in the Marshfield 
PMRP cohort. Using 1,156 fewer samples we still reproduced the genome-wide significant 
association to CETP (rs3764261, p=2.63e-13), and a highly significant association to both LPL 
(rs1441762, p=1.53e-6) and LIPC (rs11856159, p=1.59e-6). Interestingly, even though using 
modeled HDL-C as the phenotype resulted in a decreased sample size, the association signal was 
stronger for certain regions of the genome than when using median adjusted HDL-C.  For 
example, rs964184 near APOA1-APOC3-APOA4-APOA5 showed a stronger association (p=8.37e-
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7) when modeled HDL-C was used instead of median HDL-C (p=1.06e-5), as shown in Figure 23, 
top panels.  This emphasizes the need for evaulating data with and without strategies that censor 
the longitudinal strings of lipid data based on medication (e.g., niacin) and relevant co-morbidity 
(e.g., diabetes). Both are known to alter APOA1 expression. Our ability to resolve this association 
strengthened when these variables were considered. 
Conversely, some associations were attenuated in the modeled data. For example, 
rs7627293 on chromosome 3, upstream of ST6GAL1 (a sialyltransferase) and the adiponectin gene 
(ADIPOQ), was associated with median adjusted HDL-C (p=6.89e-6) but not with modeled HDL-
C (p=0.11).  This is shown in the bottom panels of Figure 23. Adiponectin is released by fat cells, 
and modulates insulin sensitivity in a variety of tissues. As weight increases, adiponectin levels 
decrease. Subjects then become insulin resistant and develop secondary defects in lipid 
homeostasis. Because our modeled HDL-C trait censors lipid observations at the first diagnoses 
of diabetes, and adjusts for BMI, the adiponectin effect on HDL-C would be obscured. In fact, it 
has been shown in a study characterizing the relationship between adiponectin levels and 
coronary artery disease (CAD) that - after adjusting for HDL-C - the effect of adiponectin on CAD 
is no longer significant (Toth, 2005). 
In general, despite using lower numbers, we observed improvement in the strength of 
association by more than two orders of magnitude, for many variants included in this genome-
wide SNP scan, when the HDL-C trait was modeled (e.g., CENTG2, COL23A1, CACNA2D1, 
CYB5B, FHOD3, GBX2, TRIB1, TLE4, TMEM135, UBE3A). As shown in Figure 24, this effect was 
most pronounced for SNPs in or near TRIB1, the Tribbles homolog 1 gene (rs2385114, an intronic 
SNP, p=8.96e-5; rs4871603, 30kb downstream, p=2.61e-6). TRIB1 was also associated at the 
genome-wide level with triglyceride concentration in our data (most significant SNP, rs6982502, 
p=3.7e-9, data not shown). Because we observed a very strong logarithmic correlation between 
median triglyceride level and median HDL-C cholesterol level (Figure 25), we further assessed 
the TRIB1-HDL-C relationship using multiple linear regression, adjusting for triglyceride  
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Figure 23. Association results from the APOA1/C3/A4/A5 and ADIPOQ loci. This shows the association 
results for two regions, APOA1-APOC3-APOA4-APOA5 (top row) and ADIPOQ (bottom row) for median 
adjusted HDL-C (left columns) and modeled HDL-C (right columns) in the Marshfield PMRP cohort. 
Color scale displays the degree of linkage disequilibrium (r²) between markers. Blue line shows 
recombination rate from HapMap CEU.  Gene location is shown along the horizontal axis of each panel.  
Here, both the APOA gene cluster region is more strongly associated with modeled HDL-C.  A SNP near 
APIPOQ is associated (p<1e-4) with median HDL-C, but this association disappears when taking other 
factors such as diabetes and medication into account with the model.  
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Figure 24. Association results for the TRIB1 region. This shows the association results for the Tribbles 1 
Homolog (TRIB1) region, without controlling for triglyceride concentration (top row) and after controlling 
for triglycerides (bottom row), for median adjusted HDL-C (left columns) and modeled HDL-C (right 
columns) in the Marshfield PMRP cohort. Color scale displays the degree of linkage disequilibrium (r²) 
between markers. Blue line shows recombination rate from HapMap CEU.  Gene location is shown along 
the horizontal axis of each panel.  This plot shows that while the statistical significance of the effect of 
TRIB1 on HDL-C levels is less compelling when adjusting for triglyceride concentration, the association is 
much stronger when using the modeled HDL-C phenotype (even though this phenotype has far fewer 
samples than the median adjusted HDL-C phenotype).  SNP rs4871603 in TRIB1 was associated with 
median HDL-C at p=7.06e-4 and with modeled HDL-C at p=2.61e-6 without adjusting for triglyceride 
concentration. After adjusting for triglycerides, the p-values for median and modeled HDL-C become less 
significant (p=0.296 and p=0.0056, respectively). 
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Figure 25. HDL-C vs. TG concentration. Median HDL-C and median triglyceride concentrations are 
highly logarithmically correlated (r²=.258). Trend line ± 95% confidence interval is shown. 
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concentration in addition to the other clinical variables (e.g., age, gender, BMI and smoking 
status).  As shown in the bottom panels of Figure 24, these associations are attenuated after 
adjustment for triglyceride levels.  
 
Gene-Gene Interaction Analysis and Replication 
We have demonstrated that biobanks linked to EMR data can provide a unique resource 
for robust replication of previous GWAS findings, and they have the capability of uncovering 
novel genetic associations.  However, as in other studies, even our most significant findings 
individually explain only a small proportion of the variance in HDL-C level. We next leverage 
both the PMRP cohort and a similarly phenotyped cohort from the Vanderbilt BioVU EMR-
linked biobank to investigate gene-gene interactions and HDL-C. Table 7 summarizes the clinical 
characteristics of the Vanderbilt BioVU population. There were 659 male (35%) and 1,199 female 
study subjects (total 1,858) with clinical laboratory records containing at least two fasting HDL 
measurements that could be used in the median HDL-C analysis. 
The number of possible SNP-SNP interactions among 522,204 SNPs is over 1.36×1011. In 
addition to being extremely computationally intensive, exhaustive evaluation of all possible 
pairwise (SNP-SNP) interactions among GWAS data comes with an extraordinary loss of power 
due to the extremely large number of statistical tests being performed. This mandates 
prioritization of which interactions to test based on some intrinsic aspect of the data or other 
extrinsic domain knowledge. One data-driven approach is to select SNPs based on the strength 
and statistical significance of their independent main effects, evaluating interactions only 
between SNPs that meet a certain effect size or significance threshold (Kooperberg et al., 2008).  
This strategy makes the simplifying but unnecessary assumption that gene-gene interactions 
affecting the phenotype can only occur between SNPs that independently have a detectable effect 
on the trait. Instead, we used the Biofilter (described in the methods section) to prioritize a small 
subset of SNP-SNP interactions to test for association with HDL-C level using existing extrinsic  
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Table 7. Descriptive statistics of clinical variables in the Vanderbilt BioVU cohort. 
 N Median Mean SD Min Max 
Age 
(years) 
2,576 57 56.56 15.85 19 90 
Weight 
(kilograms) 
2,522 85.16 88.05 24.62 36.29 251.74 
Height 
(centimeters) 
2,294 167.64 168.5 10.01 129.54 203.2 
BMI 
(kg/m²) 
2,292 29.44 30.98 7.94 14.63 72.5 
Median HDL-C 
(mg/dl) 
2,576 50.0 53.20 17.320 9.0 146.0 
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biological knowledge. It is of note that this method does not require that any SNP have an 
independent statistically significant main effect. 
We ran a gene-gene interaction analysis using multiple linear regression allowing for a 
multiplicative interaction term between the two additive-encoded SNPs. Requiring that SNP-SNP 
models be supported by at least four sources of extrinsic domain knowledge (see Statistical 
Analysis in Methods section), we tested 22,769 SNP-SNP interactions in the Marshfield PMRP 
cohort. Two test statistics were generated for each model tested: a t-test on the multiplicative 
interaction term (Pixn), and an F-test on the overall model (Pmod). A significant Pixn indicates a 
significant non-zero multiplicative gene-gene interaction between the two SNPs while a 
significant Pmod indicates a significant overall model (i.e. R²>0). We required both statistics to be 
significant in both datasets, further constraining our results to well-fitting models with strong 
evidence of non-additive gene-gene interaction.   
Using this approach, we found 11 models with a significant interaction term and 
ANOVA p-values (Pixn<0.01 and Pmod<0.05), indicative of non-additive gene-gene interaction 
contributing to median HDL-C level. These 11 SNP-SNP interaction models were then tested in 
the BioVU cohort, adjusting for two significant principal components to avoid any potential 
confounding by population stratification. Of the 11 models that were significant in the initial 
screen, six replicated in the BioVU replication cohort. Statistical significance thresholds for the 
replication cohort were slightly more liberal (Pixn<0.05, Pmod<0.1) to avoid excessive type II errors 
due to the smaller sample size.   
The results highlighting these 11 significant gene-gene interaction models are 
summarized in Table 8 (models indicated by one or more stars). The six models that show 
evidence for replication in the BioVU cohort are indicated by two or more stars. These six models 
are representative of four distinct gene-gene interactions: GALNT1-GALNT2, GALNT2-GALNT3 
(members of the GalNAc-transferases family), LPL-ABCA1 (lipoprotein lipase and ATP Binding 
Casette A1), and RPA2-RPA3 (Replication Protein A 2/3).  
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Table 8. Gene-gene interaction models. This table shows 11 significant gene-gene interaction models discovered in the Marshfield PMRP cohort (M Pixn<0.01 
and M Pmod<0.05, indicated by one to three stars). Six of these models show evidence for replication in the Vanderbilt BioVU cohort (M Pixn<0.05, M Pmod<0.1, 
indicated by two to three stars). In two of these replicating models, all three pairs of coefficients were in the same direction in both datasets (indicated by three 
stars). The table shows the two SNPs and their corresponding genes involved in the gene-gene interaction. All SNPs here were intronic SNPs. The coefficients 
for the main effects (1 and 2) and the interaction term (3) are shown for both the Marshfield cohort (prefixed by “M”), and the Vanderbilt cohort (prefixed by 
“V”). Also shown are the interaction term p-values (Pixn), ANOVA model fit p-values (Pmod), and overall R² statistics for both the Marshfield and Vanderbilt 
cohorts (prefixed by “M” and “V” respectively). 
 
REP SNP 1 Gene 1 SNP 2 Gene 2 M  1 M  2 M 3 M Pixn M Pmod M R² V  1 V  2 V 3 V Pixn V Pmod V R² 
* rs3927911 BCL2 rs4645900 BAX 0.213 3.901 -3.890 0.004 0.018 0.003 0.805 5.397 -5.808 0.042 0.154 0.003 
* rs2271709 C7 rs6699859 C8A 1.203 1.068 -1.776 0.005 0.028 0.002 -1.173 -1.176 2.433 0.020 0.138 0.003 
* rs910497 GALNT2 rs4621175 GALNT3 -0.727 -1.250 2.347 0.003 0.013 0.003 -0.890 -1.976 2.148 0.024 0.129 0.003 
* rs4621175 GALNT3 rs4846930 GALNT2 -1.213 -0.726 2.291 0.004 0.014 0.003 -1.750 -0.955 2.261 0.017 0.100 0.003 
* rs4621175 GALNT3 rs10864732 GALNT2 -1.179 -0.726 2.243 0.004 0.017 0.003 -1.641 -0.985 2.245 0.019 0.106 0.003 
** rs886724 RPA3 rs7536088 RPA2 1.493 1.713 -1.818 0.000 0.002 0.004 -2.064 -1.266 1.995 0.019 0.099 0.003 
** rs886724 RPA3 rs17257252 RPA2 0.890 1.182 -1.703 0.003 0.029 0.002 -2.035 -1.938 2.795 0.007 0.046 0.004 
** rs901675 GALNT2 rs4621175 GALNT3 1.216 2.109 -2.521 0.004 0.004 0.004 -2.114 -1.512 2.535 0.037 0.077 0.004 
** rs1471915 GALNT2 rs12963790 GALNT1 -0.410 -0.447 2.778 0.004 0.020 0.003 -2.114 0.098 -3.487 0.037 0.002 0.008 
*** rs253 LPL rs2515614 ABCA1 -0.340 -1.098 1.441 0.006 0.011 0.003 -0.618 -2.797 2.790 0.001 0.006 0.007 
*** rs253 LPL rs2472509 ABCA1 -0.338 -1.113 1.438 0.006 0.011 0.003 -0.399 -2.797 2.790 0.001 0.006 0.007 
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We then refined our results highlighting models that were significant in the Marshfield cohort, 
replicate in the BioVU cohort, and where all coefficients were in the same direction – that is, if the 
coefficient for either SNP or the interaction term is positive in the Marshfield cohort, the 
corresponding coefficient must also be positive in the BioVU dataset. This stringent criterion 
further reduced our replicating models to two similar interaction models involving LPL and 
ABCA1 (models indicated by three stars in Table 8): rs253×rs2515614 and rs253×rs2472509. These 
two models were statistically redundant - the ABCA1 SNPs (rs2515614 and rs2472509) were in 
extremely high linkage disequilibrium (r²=1 in Marshfield, r²=0.99 in BioVU), resulting in nearly 
identical coefficients and test statistics. One characteristic of this LPL-ABCA1 interaction warrants 
special emphasis. In this model the direction of the main effects (1 and 2) were all in the same 
direction, while the interaction effects were in the opposite direction. That is, in both datasets, 
inheriting a minor allele at either locus (but not both) results in a dosage-dependent decrease in 
HDL-C level, while inheriting a minor allele at both variants results in change that is significantly 
higher than the expected decrease caused by the additive effects of both variants alone.  
 
Conclusions 
 
We performed a genome-wide association analysis of HDL cholesterol level in two large 
clinical practice-based biobanks. We observed a number of previously reported associations 
between HDL-C level and genes impacting lipoprotein homeostasis (e.g., CETP, LIPC, LPL).  
Furthermore, our approach using an electronic phenotyping algorithm to censor based on clinical 
factors known to influence HDL-C cholesterol levels, allowed us to identify genes that are less 
strongly associated in the context of clinical covariates (e.g., ADIPOQ), and genes that are more 
strongly associated in the context of clinical covariates (e.g.,TRIB1). Finally, we investigated gene-
gene interaction using a novel bioinformatics approach that restricts the number of pairwise tests 
based on existing biological knowledge. 
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The primary phenotype utilized in this study was median HDL cholesterol level, derived 
from longitudinal clinical data. This trait was determined from laboratory data obtained during 
routine clinical care, and available within each subject’s individual electronic medical record. In 
the single-locus analysis, the SNP most strongly associated with median HDL-C level was 
rs3764261 (p=1.22e-25), 2.5kb upstream of the CETP transcription start site on chromosome 16.  
This SNP alone accounted for approximately 3% of the variance in median adjusted HDL-C level. 
This same variant had also been reported in another genome-wide association study in the 
Northern Finland Birth Cohort (p=6.97e-29) (Sabatti et al., 2009), and a meta analysis of three 
genome-wide association studies initially comprising 8,656 individuals and ~2,261,000 imputed 
and/or genotyped SNPs (p=2.8e-19) (Willer et al., 2008b), followed by validation in six European 
cohorts totaling 11,569 individuals (p=6.4e-43) (Willer et al., 2008b).  Other studies have found 
different SNPs in the region upstream of CETP to be even more highly associated with HDL 
cholesterol levels: rs1800775 (p=1e-73) in  (Kathiresan et al., 2008), rs173539 (p=4e-75) in 
(Kathiresan et al., 2009) where samples were combined from the two previously cited studies, 
and rs1532624 (p=9.4e-94) in (Aulchenko et al., 2009). The SNP with the strongest association in 
our dataset (rs3764261) is in LD with an eQTL SNP which affects mRNA levels of CETP in 
HapMap lymphoblastoid cell lines (Veyrieras et al., 2008). The CETP gene product has known 
biological relevance, redistributing cholesterol esters between HDL-C particles and the larger, 
more atherogenic lipoproteins.  
Free fatty acids and TG are liberated from HDL-C particles through the activity of three 
well-characterized lipolytic enzymes (LIPC, LIPG, and LPL). In our dataset, a SNP in the first gene 
reaching genome-wide significance for association with HDL-C level was rs11855284 (p=3.90e-
14), 13.5kb upstream of the hepatic lipase (LIPC) transcription start site on chromosome 15.  
Further, our most significant signal that did not meet genome-wide significance was rs12678919 
(p=1.99e-7), a SNP in an intergenic region 19kb downstream of lipoprotein lipase (LPL) on 
chromosome 8. Thus, we observed association with LPL and LIPC but not LIPG. These 
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observations are consistent with existing biological knowledge. The enzymatic activity of LPL 
favors lipolysis of TG (i.e., phospholipase activity is relatively minor). TG rich HDL-C particles 
are less stable, and are quickly shuttled back to the liver for elimination, as SRB1 mediated 
removal is a function of TG enrichment in HDL-C particles. Conversely, LIPG has relatively little 
TG-lipase activity, (i.e., primarily a phospholipase), and any common variants that affect 
expression or function of LIPG would have small effect on HDL-C stability, requiring a very large 
sample size to detect an association (~9,800 samples to achieve 80% power to detect an effect of 
similar magnitude as has been previously observed for LIPG (Willer et al., 2008b) at p=1e-7). 
Nascent HDL-C particles contain two copies of Apo-A1 and very little lipid (less than 
10%)  (Lewis & Rader, 2005). In our data, HDL-C level showed suggestive association with the 
APOA1/C3/A4/A5 locus (rs964184, p = 1.06e-5), adjusted for age, gender, BMI, smoking status, 
and family relatedness. As shown in Figure 23, the HDL-C association with APOA1/C3/A4/A5 
locus was strengthened (p=8.37e-7) when we used our previously published approach to 
modeling HDL-C within an electronic record, which censors data based on relevant co-
morbidities (e.g., diabetes mellitus) and lipid modifying medications (e.g., niacin). Medications 
such as niacin are highly efficacious at increasing HDL-C level. Niacin increases HDL-C level 
approximately 30% (Joy & Hegele, 2008). While fibric acid derivatives also increase HDL-C, they 
are far more efficacious at reducing TG (Joy et al., 2008). HMG CoA reductase inhibitors (statins) 
have modest but reproducible beneficial effects on both HDL-C and TG levels (Yee & Fong, 1998; 
1984; Shepherd et al., 1995; 1994).   When our data were censored based on first exposure to a 
lipid modifying medication, or first co-morbidity known to alter lipid homeostasis (Wilke et al., 
2010), the association between HDL-C and APOA gene cluster variants increased by two orders 
of magnitude. We therefore scanned our genome-wide SNP data to identify other variants that 
were more strongly associated using this approach. SNPs in or near TRIB1 were also strongly 
associated with modeled HDL-C level. In our data, HDL-C and TG levels were logarithmically 
correlated (Figure 25), and the association between rs4871603 in TRIB1 and HDL-C (p=2.61e-6) 
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was markedly reduced after adjusting for TG (p=0.0056). Further study is warranted to fully 
characterize the biology underlying this interaction. TRIB1 may serve as a clinical surrogate for 
the triglyceride effect on HDL-C concentration. TRIB1 encodes a G-protein-coupled-receptor 
induced protein involved in the function of mitogen-activated protein kinases (Kiss-Toth et al., 
2004), and the role of HDL-C in reverse cholesterol transport  may be modulated through such an 
interaction (Ghosh, Ghosh, Gehr, & Sica, 2004; Miller et al., 2007; Grewal et al., 2003). Because 
TRIB1 has previously been associated with coronary artery disease (Aulchenko et al., 2009; 
Kathiresan et al., 2008; Kathiresan et al., 2009; Willer et al., 2008b), the TRIB1-HDL-C relationship 
observed within our data may have a profound impact on public health.  
Our most significant findings, however, still explain less than 3% of the variance in HDL-
C level, a trait that is up to 70% heritable. We therefore examined a small subset of all the possible 
gene-gene interactions in our GWAS data. We found 11 interactions that were nominally 
significant in our discovery cohort (the Marshfield PMRP biobank). After evaluating these 
models in a validation sample (Vanderbilt BioVU cohort), we found that six of the 11 models 
replicated. We required both the p-value on the interaction term and the p-value on the ANOVA 
F-test for the regression model to be significant in both datasets, further constraining our results 
to models with evidence of nonlinear gene-gene interaction in a well-fitting model. These models 
individually explained 0.2-0.8% of the variation in HDL-C in the Marshfield and BioVU cohorts 
(see Table 8). Only one set of observed gene-gene interactions showed evidence of replication in 
both datasets with consistent directionality in all three coefficients: LPL and ABCA1. Because we 
required evidence of replication with consistent direction of effect in a second dataset, we did not 
require a stringent multiple testing correction. While it would be possible to randomize the 
outcome data and permute this entire procedure, this method of permutation testing would be 
computationally expensive, and thus was not performed here. LPL mediates the release of free 
fatty acids and TG from HDL-C particles, while ABCA1 moves free cholesterol into HDL-C 
particles as they undergo intravascular remodeling. Thus, it is not surprising that we observed a 
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statistically meaningful interaction between variants in these two genes. It is however surprising 
that the direction of the main effect coefficients (1 and 2) were in the same direction while the 
interaction effect was in the opposite direction. While still considered a nonlinear epistatic 
interaction, the structure of the model in Table 8 is referred to as a heterogeneity model (Cordell, 
2002; Neuman et al., 1992) rather than a synergistic multiplicative model. In a separate study of 
type I diabetes, investigators found that four out of five statistically significant gene-gene 
interactions were also of this type (Barrett et al., 2009). Genetic heterogeneity is often blamed for 
the lack of replication in GWAS studies (McClellan et al., 2010; Sillanpaa et al., 2004). Others have 
recently argued that epistatic genetic heterogeneity should be considered when analyzing genetic 
data for association to complex human traits (Moore et al., 2010b). Despite the fact that statistical 
tools, such as random forests, have been available for some time now to accomplish this (Lunetta 
et al., 2004; Thornton-Wells et al., 2004), analyses of GWAS data accounting for the possibility of 
epistatic heterogeneity is a task rarely undertaken.  Accounting for genetic heterogeneity in 
genetic studies of complex disease may improve the replicability of findings in genome-wide 
studies of gene-gene interactions in lipid and other complex human phenotypes. 
Here we have used EMR data from genotyped biobanked samples to perform the first 
knowledge-based gene-gene interaction analysis for HDL-C. Using a second EMR-linked biobank 
cohort we demonstrated evidence for replication of a gene-gene interaction between LPL and 
ABCA1. As demonstrated here and elsewhere (Ritchie et al., 2010; Denny et al., 2010a), biobank-
linked EMRs provide an excellent resource for genetic studies of complex traits. By utilizing the 
EMR to construct a rigorous phenotype and by accounting for gene-gene interaction as presented 
here, perhaps more variation can be explained and new biology discovered in complex traits like 
HDL-C level. 
 
 
 
124 
 
Acknowledgements 
 
The work presented in Chapter V was supported in part by NIH grants F31-NS066638, 
R01-LM010040, U01-HG004608, and U01-HG04603.  
125 
 
CONCLUSION 
 
 
The “missing heritability” problem (Maher, 2008) discussed in the previous chapter is a 
familiar phenomenon that is shared among nearly every complex human disease or 
morphological phenotype. Twin and adoption studies show that many complex traits are 
heritable, yet GWAS, dispite its many successes (Hindorff et al., 2009), has consistently failed to 
explain any appreciable amount of this heritability for most complex traits. This does not mean 
that GWAS has failed; on the contrary, many GWAS studies have produced highly replicable 
results and have led to the discovery of new biology (Manolio et al., 2009). A notable example 
was the discovery of the involvement of complement factor H (CFH) in age-related macular 
degeneration (AMD). Four years after the CFH association was discovered using GWAS and 
other study designs (Klein et al., 2005; Haines et al., 2005; Edwards et al., 2005), researchers have 
shown that inhibiting the alternative complement pathway can reduce vascularization of the 
retina (a symptom of the “wet” form of AMD) in a mouse model of AMD.  
GWAS home-runs like the CFH association with AMD – where the first odds ratio 
reported was 7.4 – are very seldom found for most complex human traits. As discussed 
throughout this dissertation, the standard single-SNP-at-a-time approach to GWAS ignores the 
complexity of biological systems. Accounting for this complexity in an analysis may enable the 
discovery of disease-predisposing genetic variation that would otherwise remain elusive.  
After reviewing the state-of-the-art for analysis of GWAS data in Chapter I, I presented in 
Chapter II a series of improvements on an existing algorithm for finding multi-locus genetic 
associations to complex traits that uses grammatical evolution to train neural networks (GENN). 
This chapter drew from several previously published works showing that using a memetic 
algorithm by incorporating backpropagation with grammatical evolution, in combination with 
initializing the neural network population in part from domain knowledge can greatly improve 
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the ability of GENN to discover gene-gene interactions impacting complex diseases (Turner et al., 
2010b; Turner, Dudek, & Ritchie, 2010c; Turner, Dudek, & Ritchie, 2010a).  
“Epistasis” is often used interchangeably with “gene-gene interaction,” implying that 
variation in two or more different genes are involved. Chapter III explored a different kind of 
epistasis, one that involves variation in regulatory sequences in or around a single gene. Here we 
defined cis-epistasis as the non-linear effect on a gene’s expression of multiple variants within a 
500kb region of potential transcriptional influence. Here we found 706 significant cis-epistasis 
interactions that influence the expression of 79 unique genes. We then investigated the genomic 
and statistical structure of these interactions, mapped these genes and SNPs to previously 
reported associations to human disease and morphological phenotypes, and suggested ways in 
which analysis of future datasets or reanalysis of existing datasets may account for cis-epistasis in 
an interaction analysis. 
In Chapter IV I discuss quality control procedures and best practices for GWAS data. 
These procedures were used prior to the analysis that was presented in Chapter V – a GWAS 
investigating both single-locus association with HDL-C in the context of environmental variables, 
and interrogating gene-gene interactions that affect HDL-C using a knowledge based-approach. 
Using phenotypes abstracted from the electronic medical record linked to DNA from biobanked 
samples we discovered a potentially new HDL-C gene and replicated several known genetic 
associations with HDL-C. Using a knowledge-based approach we identified 11 gene-gene 
interactions in one biobank cohort, with 6 of these showing evidence for replication in a second 
similarly phenotyped cohort. These results demonstrate the power of linking electronic medical 
records to GWAS data from biobanked samples and using prior biological knowledge to guide a 
gene-gene interaction analysis for complex human traits. 
The studies that comprise Chapter II (Turner et al., 2010b; Turner et al., 2010c; Turner et 
al., 2010a) evaluated improvements in the GENN/ATHENA training algorithm using simulated 
datasets containing 500 SNPs, where the amount of variance, or heritability, explained uniquely 
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by the main effect and interaction variance components was 1% and 5% respectively. During the 
planning phases of these works, it was thought that while single SNPs individually could only 
explain a small portion (1-3%) of the variance of complex traits, perhaps gene-gene interactions 
could individually explain a larger portion of complex trait variance (up to 5%). Pervasive 
epistasis with large effects exist in animal models (Shao et al., 2008), and could theoretically exist 
in humans as well (Li & Reich, 2000). However, effects this large are rarely found for common 
variants, whether alone or in combination with other variants. Our most significant, replicating 
two-SNP models affecting HDL-C levels presented in Chapter V explain less than half a percent 
of the variance in HDL level each.  
Although we have made tangible improvements to the GENN/ATHENA training 
algorithm (Chapter II), many more improvements are necessary before such an approach is 
adequately powered to detect effects in GWAS or sequencing data. In Chapter II I presented a 
method for sensibly initializing GENN/ATHENA with genes implicated in a shared biological 
mechanism. After initialization, stochastic computational evolution rearranged solutions, fitted 
weights, and performed variable selection. A potential algorithmic improvement would utilize 
our wealth of biological knowledge throughout the training process, rather than at initialization 
only. Here, genes having SNPs as inputs to well-performing NN solutions could be mapped back 
onto known biological pathways, protein families, gene ontologies, or signal transduction 
pathways, midway through training. NNs with poor performance could be replaced with NNs 
containing SNPs from other genes in these known biological gene groupings, and stochastic 
computational evolution would resume. In this two-step procedure, the first iteration of training 
would find promising regions of the solution space, while the second iteration would hone in on 
the best solutions in a region. This process could be repeated iteratively, rather than a two-step 
procedure. From a software engineering perspective, massive performance improvements could 
potentially be made by rewriting code that would allow ATHENA to run on modern PC graphics 
cards, called graphics processing units (GPUs). A single typical GPUs can have hundreds of 
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processors running in parallel, and GPU floating point performance doubles every year, rather 
than every 18-24 months for personal computer CPUs (Poli et al., 2008). Another group has 
recently ported the Multifactor Dimensionality Reduction (MDR) algorithm to a GPU 
implementation, and found that the GPU implementation running on the graphics card of a 
single workstation outperformed an optimized C++ implementation running on 150 cores on a 
Beowulf cluster (Sinnott-Armstrong, Greene, Cancare, & Moore, 2009). The faster-than-Moore’s-
law (Moore, 1965) performance increases of GPUs, and the parallel nature of GENN makes GPU 
implementation a very promising avenue of future development. 
In addition to the methodological research discussed above, there are several additional 
analytical approaches that future research should focus on to gain the most information possible 
from existing data. As discussed in the introduction, the pace of technological innovation in the 
genotyping laboratory is staggering. The completion of the pilot phase of the 1000 Genomes 
Project has shed light on patterns of genome-wide genetic variation in multiple populations 
(Durbin et al., 2010). Although whole-genome sequencing in thousands of samples is still 
prohibitively expensive, this resource will facilitate imputation, or inference, of alleles at untyped 
loci. As demonstrated with an eQTL locus in the pilot project, using 1000 Genomes Project 
reference haplotypes for imputation will allow more fine-grained mapping of GWAS hits than 
using HapMap II imputation or genotyped markers alone (Durbin et al., 2010). Finally, a recently 
published perspective argued that performing GWAS with increasingly larger sample sizes will 
not yield meaningful discoveries, especially if the newly detected loci explain such a small 
proportion of the heritability of the trait being studied (Goldstein, 2009). A recent lipids meta-
analysis to date, using over 100,000 samples, recently provided the first empirical evidence to 
refute such claims. Teslovich et al. analyzed over 100,000 samples of European descent and 
identified 95 loci (59 novel) associated with either total cholesterol, LDL, HDL, or triglycerides, 
several of which demonstrated clear clinical and/or biological significance, albeit with small 
effect sizes (Teslovich et al., 2010). Efforts are ongoing to impute data from the cohorts presented 
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in Chapter V using 1000 Genomes Project reference haplotypes, and to contribute to the next 
lipids meta-analysis, which will comprise the largest lipids genetic analysis to date. Finally, 
future research should aim to unravel the influences of genes and environment by performing 
cross-cultural studies of disease risk using diverse, non-European cohorts. Because rates of 
genetic and environmental exposures and disease prevalence differ between populations around 
the world, it is possible to unravel the relative contributions of environmental and inborn risks 
(Kolonel, Altshuler, & Henderson, 2004). With the maturation of new genotyping and sequencing 
technology, acquisition of increasingly large and diverse cohorts, and development of powerful 
and robust statistical methodology, we are well positioned to begin accounting for nonlinear joint 
effects between multiple SNPs and environmental exposures which will explain more variation 
in complex traits, driving personalized medicine and enabling the discovery of new biology. 
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